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ABSTRACT OF DISSERTATION
Relation Prediction over Biomedical Knowledge Bases for Drug Repositioning
Identifying new potential treatment options for medical conditions that cause hu-
man disease burden is a central task of biomedical research. Since all candidate
drugs cannot be tested with animal and clinical trials, in vitro approaches are first
attempted to identify promising candidates. Likewise, identifying other essential re-
lations (e.g., causation, prevention) between biomedical entities is also critical to
understand biomedical processes. Hence, it is crucial to develop automated rela-
tion prediction systems that can yield plausible biomedical relations to expedite the
discovery process. In this dissertation, we demonstrate three approaches to predict
treatment relations between biomedical entities for the drug repositioning task us-
ing existing biomedical knowledge bases. Our approaches can be broadly labeled as
link prediction or knowledge base completion in computer science literature. Specif-
ically, first we investigate the predictive power of graph paths connecting entities
in the publicly available biomedical knowledge base, SemMedDB (the entities and
relations constitute a large knowledge graph as a whole). To that end, we build lo-
gistic regression models utilizing semantic graph pattern features extracted from the
SemMedDB to predict treatment and causative relations in Unified Medical Language
System (UMLS) Metathesaurus. Second, we study matrix and tensor factorization
algorithms for predicting drug repositioning pairs in repoDB, a general purpose gold
standard database of approved and failed drug–disease indications. The idea here is to
predict repoDB pairs by approximating the given input matrix/tensor structure where
the value of a cell represents the existence of a relation coming from SemMedDB and
UMLS knowledge bases. The essential goal is to predict the test pairs that have a
blank cell in the input matrix/tensor based on the shared biomedical context among
existing non-blank cells. Our final approach involves graph convolutional neural net-
works where entities and relation types are embedded in a vector space involving
neighborhood information. Basically, we minimize an objective function to guide our
model to concept/relation embeddings such that distance scores for positive relation
pairs are lower than those for the negative ones. Overall, our results demonstrate that
recent link prediction methods applied to automatically curated, and hence imprecise,
knowledge bases can nevertheless result in high accuracy drug candidate prediction
with appropriate configuration of both the methods and datasets used.
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Chapter 1 Biomedical Knowledge Discovery
Manual analysis and exploration of medical data is increasingly becoming non-trivial
given the exponential growth in numbers and sizes of such datasets owing to ad-
vances in data science and general quality of EMRs. Therefore, there is a lack
of automatic processing systems for not only analyzing the data but also discov-
ering/extracting any previously unknown relationships between biomedical entities
such as treatment-causative relations or drug-drug interactions (Cheng et al., 2014;
Zhang et al., 2014c). In order to automate manual operations on a vast amount of
rapidly growing biomedical data, many researchers employ computational methods
including machine learning (ML) and natural language processing (NLP) as well as
graph modeling techniques (Cameron et al., 2015b; Wilkowski et al., 2011; Workman
et al., 2016; Zhang et al., 2011). This process of using automated methods to elicit
new information is generally termed as knowledge discovery.
In biomedical domain, knowledge can be defined as meaningful interpretation
or information that can be gleaned from a medical dataset, available either in a
structured form or textual form. In general sense, this could mean named entities
of interest to users, such as names of drugs, diseases, and procedures. High level
knowledge typically involves interactions between these extracted biomedical named
entities. For example, there is typically a treatment relation between a drug and a
disease. Here, these interactions are generally called relations that connect a subject
entity (drug) with an object entity (disease) through a predicate (treats). Beyond
just named entities, a set of meaningful relations extracted from a dataset can also be
construed as a more specific kind of knowledge. However, indirect or implicit relations
might exist and can be obtained by putting together several known relations as a
sequence where the entities at either end of the sequence are now seen as participating
in a new relation. But this can only happen when the nature of entities and predicates
along the sequence is meaningful to derive this new connection. For example, consider
this sequence of two relations with stimulates and treats predicates in that order
below:
Mercaptopurine −−−−−−→
Stimulates
Cytarabine triphosphate −−−−→
Treats
Leukemia
From the two constituent relations taken in this specific order, we can now see
a potential new relation: (Mercaptopurine - treats - Leukemia). In fact, this is
known to be a known relation between Mercaptopurine and Leukemia. Hence, this
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information is called implicit knowledge as it is not explicitly expressed in medical
textual narratives or structured data sources.
Many simple paths or sequences of relations clearly do not all lead to new undis-
covered relations. Even when they do, they may not sometimes be interpretable in
a biomedical sense due to missing additional context. There are cases where a com-
pact subgraph connecting a pair of entities is essential in inferring a new implicit
relation (Cameron et al., 2015b). Hence, the process of discovery might also in-
volve identifying interesting subgraphs that convey a richer and more comprehensive
overview of the new relation.
At a high level, for the purposes of this thesis, knowledge discovery entails discov-
ery of new binary relations (e.g., treatment, causative, preventative) connecting pairs
of biomedical entities based on existing relation databases that are either manually
curated (not uncommon in medicine, such as the unified medical language system
(UMLS) Metathesaurus (National Library of Medicine, 2009)) or automatically cu-
rated (through NLP methods, such as the Semantic Medline Database (National Li-
brary of Medicine, 2016)). This discovery is carried out through a prediction process
typically modeled by machine learning methods. A particular focus is on the drug
repositioning problem, where based on existing knowledge about already approved
drugs or drugs that were found to be safe in humans, new use-cases of drugs are iden-
tified for specific new conditions. That is, the repositioning task is a special case of
knowledge discovery where one predicts treatment relations from existing treatment
relations or a much larger set of relations involving other predicates. Given predic-
tion is inherently prone to errors, hypothesis generation is sometimes employed as a
more appropriate name sometimes employed by researchers to discuss computational
methods for knowledge discovery.
1.1 Thesis Statement and Summary
Discovering (and as a first step, hypothesizing) new biomedical relations is a core task
in advancing biomedical research. Specifically, identifying new viable drug candidates
for diseases is vital due to the excessive time and financial cost burden of a tradi-
tional drug development pipeline. Our hypothesis is that advances in link prediction
methods that are carefully configured and applied to existing knowledge bases (cu-
rated either manually or in an automated manner) can aid in building high accuracy
models for relation prediction in general and specifically, for drug repositioning. We
verify this hypothesis using three different efforts.
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First, we employ logistic regression models that use semantic graph patterns con-
necting pairs of entities to this end and predict treatment and causative relations.
Although effective, extracting pairs of all paths (from which patterns are derived)
of lengths ≤ k quickly becomes intractable even for small k (e.g., k ≥ 4) for mod-
erately dense graphs. Next, we explore and show that matrix completion through
low-rank approximation via nonnegative matrix factorization (NMF) can be a sim-
pler and more efficient method that can be configured for the specific task of drug
repositioning using the UMLS and SemMedDB knowledge bases. Although much
faster, matrix completion methods cannot identify new viable drug–disease pairs for
drugs for which there is not even a single prior known positive treatment relation
(with some other condition). A drug that is not FDA approved for any condition
may still be a viable candidate for other conditions if the clinical trails that failed
did not show any adverse affects in humans (besides simply being ineffective for the
conditions it was considered for approval). To address these scenarios, in our final
effort, we use tensor factorization (TF) and the more recent graph convolutional net-
works (GCNs) with neural embeddings of the entities and relations (∈ Rd) as more
effective alternatives for drug candidate prediction (even for drugs without a single
prior known treatment relation). We demonstrate that these methods improve recall
by trading off precision in comparison with matrix completion methods. At a high
level the intuition for this effect is the ability of TF and GCN methods to exploit
multi-hop connections between candidate drugs and diseases to predict new relations.
Owing to a potential complementary evidences captured by each of our methods, an
ensemble model that combines NMF, TF, and GCN predictions performs better than
all three constituent models in terms of F1-score. For the second and third efforts,
we use the repoDB (Brown and Patel, 2017) dataset that was explicitly created to
evaluate computational drug repositioning efforts, and includes both FDA approved
drugs and failed indication from ClinicalTrials.gov.
1.2 Organization
The remaining chapters in this dissertation are organized as follows:
Chapter 2 presents relevant prior efforts on biomedical relation prediction and knowl-
edge discovery. The notations used throughout this manuscript and the evaluation
metrics used are also introduced here. This chapter briefly covers the basics of
supervised machine learning and the fundamental definitions of the algorithms uti-
lized in each chapter.
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Chapter 3 introduces a novel and intuitive approach which exploits semantic graph
patterns as features to predict treatment and causative relations between any given
pair of biomedical entities. We build logistic regression (LR) and decision tree (DT)
models with graph pattern features. We also provide the details about the potential
of graph patterns in terms of coverage and utility of highly discriminative patterns
identified through coefficients of our best LR model.
Chapter 4 details matrix completion through NMF for drug repositioning. First,
we describe how we applied the factorization approach by curating treatment re-
lations from SemMedDB and UMLS Metathesaurus to form the input matrix for
the factorization process. Then, we discuss the NMF ‘scores’ for the repoDB pairs
and predictive performance of a few NMF models. In addition, we present the in-
fluence of exploiting chronological information of input treatment relations (when
they were first reported in literature) on the NMF scores of the drugs in approved
treatments in repoDB test set.
Chapter 5 describes tensor factorization and knowledge graph embeddings with the
GCN methods for classifying drug repositioning test pairs. We details the config-
urations of our models along with their performance scores compared with each
other for the repoDB test pairs. We also present a simple ensemble model based
on majority voting built with the best NMF, TF, and GCN configurations and
evaluate its performance. Finally, we conduct error analyses and evaluations for
the false positive and false negative predictions in collaboration with clinicians.
Chapter 6 summarizes this dissertation with the results and contributions from
different experiments conducted in all other chapters. Besides this, we discuss
several advantages and disadvantages of each method as well as the limitations
and the future directions.
1.3 Related Publications
This dissertation contains material previously published in the following papers:
• Gokhan Bakal and Ramakanth Kavuluru. Predicting Treatment Relations
with Semantic Patterns over Biomedical Knowledge Graphs. In the Proceeding
of the International Conference on Mining Intelligence and Knowledge Explo-
ration (MIKE) 2015 (pp. 586-596). [Chapter 3]
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• Gokhan Bakal, Pretham Talari, Elijah V. Kakani, and Ramakanth Kavuluru.
Exploiting Semantic Patterns over Biomedical Knowledge Graphs for Predicting
Treatment and Causative Relations. In: Journal of Biomedical Informatics, 82,
2018 (pp. 189-199). [Chapter 3]
• Gokhan Bakal, Halil Kilicoglu, and Ramakanth Kavuluru. Non-Negative
Matrix Factorization for Drug Repositioning: Experiments with the repoDB
Dataset. (To appear in the Proceedings of the AMIA 2019 Annual Sympo-
sium). [Chapter 4]
The papers which are either submitted or under preparation are below:
• Gokhan Bakal, Romil Chadha, Tushi Singh, and Ramakanth Kavuluru. Pre-
dicting Drug Repositioning Pairs with Tensor Factorization and Graph Convolu-
tional Networks. (Under preparation to be submitted to Journal of Biomedical
Informatics or the Journal of American Medical Informatics Association).
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Chapter 2 Related Work and Background
Given the exponential growth (Lu, 2011) of scientific literature, it is unrealistic to
manually review all articles published on a given topic. Therefore, natural language
processing (NLP) techniques have been increasingly used to extract biomedical re-
lations from free text documents. For instance, the treatment relation example dis-
cussed earlier in this section may be extracted from the sentence – “We conclude that
Tamoxifen therapy is more effective for early stage breast cancer patients.” However,
NLP extractions are essentially based on evidence present in particular sentences and
are prone to two types of errors. First, the NLP techniques themselves might not be
foolproof and second the evidence found in a particular sentence might be circum-
stantial and not something that is universally accepted. Nevertheless, extraction of
the same relation from multiple sentences might be indicative of the strength of the
relation if it is being reported by multiple research projects.
Binary relations are typically encoded as (subject, predicate, object) triples and
can be obtained from (1). well known expert curated knowledge bases, (2). applying
NLP techniques to free text from literature, or (3). employing global lexico-syntactic
pattern based methods. Due to excessive time consumption involved in manual cura-
tion, knowledge bases are generally not complete/exhaustive (Xu et al., 2013). NLP
approaches can be used to extract relations from particular sentences using the lin-
guistic structure of a sentence (syntactic/dependency parse) especially involving the
spans of named entities that occur in it (Abacha and Zweigenbaum, 2011; Fundel
et al., 2007; Kavuluru et al., 2012; Kim et al., 2015; Segura-Bedmar et al., 2011).
Even though such systems are popular for relation extraction, they are error prone
and might result in extraction of coincidental outcomes that cannot be considered
general knowledge. Furthermore, implicit relations that are not necessarily asserted
in a sentence cannot be obtained through such approaches. However, NLP extractions
can be used as a basis to develop more advanced techniques that aim toward a global
relation prediction modeling paradigm. This process of distilling the literature and
gleaning actionable information that drastically reduces researcher efforts in dealing
with information explosion is termed as literature-based discovery (LBD).
An alternative approach for the LBD is distant supervision (Mintz et al., 2009)
(also called “weak supervision”) when there are many predicates and manual labeling
of sentences with relations is impractical. In this approach, pairs of entities, which
come from a high quality knowledge base, are known to participate in specific relations
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and are used to search literature to identify sentences that contain both of them.
Such sentences are used as training instances for the corresponding predicates to
learn lexico-syntactic patterns that could be used as features in supervised models or
in ranking new relations using unsupervised approaches (Xu et al., 2009). Although
distant supervision offers a convenient approach to overcome the labeled data scarcity
issue, a disadvantage is that existence of a pair of entities in a sentence does not
directly mean that the sentence is expressing the particular relation existing in the
knowledge base. Another important disadvantage is that the knowledge base could be
incomplete and hence negative example pairs (those that do not participate
in a relation in the knowledge base) may not be true negatives. Even
though these disadvantages were comparatively mentioned and obviated by some
other approaches (Riedel et al., 2010; Ritter et al., 2013; Surdeanu et al., 2012; Xu
et al., 2013), few researchers have addressed these issues especially in biomedicine. In
our first effort in Chapter 3, we propose an approach that is very different from these
existing popular methods by relying on the graph path patterns extracted from a
large graph of extracted relations using NLP approaches. As such, our methodology
is not “extracting” a relation form a particular sentence, but is rather “predicting” a
relation based on the implicit connections between the corresponding entities.
Similar to the relation extraction studies on the scientific literature, drug reposi-
tioning efforts have also gained an influential role against the traditional drug develop-
ment methods. More interestingly, computational drug repositioning (CDR) studies
help clinical researchers to shorten the drug discovery process by exposing more plau-
sible candidate indications for the approved drugs. Since the scientific literature of
treatment data has been exponentially growing, many computational approaches have
been employed to explore new indications for the drugs (Li et al., 2016). Hence, the
similarities of major characteristics of drugs such as chemical structures, molecular
level activities, and side effects are the essential research directions for discovering
new indications. Beyond the similarity based efforts, exploiting ontologies (Zhu et
al., 2014) and drug-target networks (Li and Lu, 2012) as well as utilizing available
large-scale genomic data sources (Dudley et al., 2011) are the other recent studies.
Unlike the CDR efforts mentioned above, we exploit matrix and tensor factor-
ization and graph convolutional neural networks (GCN) approaches to predict drug
repositioning pairs in repoDB. Factorization based algorithms are successfully applied
to diagnostics of test results, analysis of genomic data, and completion of the elec-
tronic health records in biomedical domain (Luo et al., 2016; Roy et al., 2014; Wang
et al., 2015). The elegance here is that the learned low dimensional latent embed-
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dings capture the underlying patterns among the matrix/tensor entries for relation
prediction and other various tasks such as document clustering and recommendation
systems.
On the other hand, using neural embeddings of the nodes and edges in a knowl-
edge graph is extensively studied for the knowledge graph completion task (Nickel
et al., 2011; Yang et al., 2014; Wang et al., 2014; Ji et al., 2015; Trouillon et al.,
2016). Similarly, GCN techniques are also utilized for several tasks such as learning
molecular fingerprints for drug efficacy and predicting relations with muti-relational
data (Duvenaud et al., 2015; Schlichtkrull et al., 2018). To that end, we utilize
the embeddings of the semantic predications from SemMedDB and UMLS graphs.
Besides, we also exploit the GCN algorithm which enhances the entity embeddings
by considering the neighborhood information. Ultimately, we build models exploiting
matrix/tensor factorization and GCN with SemMedDB and UMLS Metathesaurus to
predict approved and failed drug-disease pairs in repoDB. Moreover, we demonstrate
that the factorization and GCN models are both efficient on the relation prediction
task while resulting in satisfactory predictive performance.
2.1 Notation
In this dissertation, vectors are represented as bold lower case letters (e.g. x, w
and z); matrices are denoted as bold upper case letters (e.g. X, W and H) and
high dimensional tensors are represented as upper case letters with Euler script font
(e.g. X , T and K). Subscripts are used to differentiate different elements and vectors
(e.g. xi,wi and Xi,Wi). Superscripts are used to represent the value of the recent
iteration/case for an argument (e.g. xl+1).
2.2 Supervised Machine Learning
The aim of supervised learning is to learn from already labeled training examples
and predict labels for new unseen instances. In this dissertation, we focus on binary
classification, where the main goal is to have machine learned models, which can gen-
eralize examples from training dataset, to assign a label, y ∈ {0, 1}, to every example
in test dataset. Each example is represented by a n dimensional feature vector x =
(x1, .., xn), where every feature xi denotes unique predictive information. In order to
generate this feature representation, examples are required to be transformed from
the input space (e.g. frequencies of semantic patterns that exist between biomedical
entities) into the n dimensional feature space. For supervised learning approaches (we
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utilized one of them; logistic regression in Chapter 3), the learning algorithm uses m
labeled example pairs, {(x1, y1), .., (xm, ym)} where yi is the related label of feature
vector xi for each example i. Afterwards, the algorithm learns a statistical model on
training dataset, which can be utilized to predict class labels on a test example with
the same n dimensional feature vector. Some of the most widely used algorithms in
supervised classification are naïve bayes, decision trees, k-nearest neighbors, logistic
regression, support vector machines (SVM), and artificial neural networks.
2.2.1 Matrix & Tensor Factorization Techniques
Low-rank approximations of matrices and tensors via factorizations (or decomposi-
tions) play a major role in exploiting the data and extracting latent components
for several applications such as text mining (Kuang et al., 2015), computer vi-
sion (Koudelka and Dorsey, 2016), and financial data analysis (Fréin et al., 2008). In
our case, the essential goal is to predict biomedical relations, particularly the treat-
ment relation. In order to implement such a system, we employ non–negative matrix
factorization technique (also known as non-negative matrix approximation) which
is a method in linear algebra where a matrix Xm×n is factorized into two matrices
Wm×k and Hk×n with a special property that all three matrices have no negative
elements and Xm×n ≈ X̂
m×n
= Wm×k × Hk×n as illustrated in Figure 2.1 where
k  min(m,n). Particularly, nonnegativity constraint can be considered as a part-
based representation in which a zero-value represents the absence while a positive
value indicates the presence of some connections between entities. A more elaborate
explanation is provided in Chapter 4.
Figure 2.1: Schematic for matrix completion over non-negative matrix factorization
Matrix factorizations only have two modes or 2-way representations. Tensor fac-
torization is considered as a higher-order extension of matrix factorization that cap-
tures the underlying latent patterns in multi-relational data sets where there is more
than one predicate. Similar to matrix factorization, tensor factorization is frequently
employed in several disciplines including bioinformatics, image analysis, and signal
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processing. There are two essential techniques for the tensor factorization: the Tucker
decomposition and PARAFAC (also known as CANDECOMP/PARAFAC - or as CP)
decomposition. In this dissertation, the CP tensor decomposition is used and can be
thought of as singular value decomposition (SVD) analogue for tensors.
2.2.2 Neural Networks Algorithm
Neural networks (NN) algorithms are a class of supervised methods in machine learn-
ing capable of learning a subspace of nonlinear functions. A typical neural network is
built with interconnected elements called artificial neurons. Neural networks can have
one or multiple layers of artificial neurons. For instance, the multi-layer perceptron
(MLP) is a class of feed-forward artificial neural networks and consists of at least
three layers of nodes: an input layer, a hidden layer and an output layer as shown
in Figure 2.2. Each layer has a number of processing units and each unit is fully
connected with weighted connections to the units in the previous layer. The output
layer can also include a sigmoid unit if the goal is classification (instead of regression).
Since the parallel architecture in a Graphics Processing Unit (GPU) is well adapted
for vector and matrix operations, NN algorithms run faster on GPU systems.
Input
layer
Hidden
layer
Output
layer
Input 1
Input 2
Input 3
Input 4
Input 5
Output
Figure 2.2: An example of a typical feedforward neural network
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Neural networks models are typically built to utilize data represented as feature
vectors. In Chapter 5, we handle graphs as input data, which lack input in feature
vectors representation. Thus, before we examine the neural networks model that can
handle graphs, it is essential to explain convolutional neural networks (CNN) first
because graph convolutional neural networks (GCN) are built on the CNN principle.
2.2.3 Convolutional Neural Networks
A typical CNN model is a type of feed-forward neural network and consists of an
input layer, multiple hidden layers, and an output layer. The hidden layers of the
CNN basically consist of convolutional layers, an activation layer, pooling and fully
connected layers. Here, the convolution layer is the core process of the CNN model
which extracts features from the training dataset. For instance, if we would like to
learn features for an image, then the convolution operator will collect the spatial
associations between pixels with predefined convolution filters over the image (Zeiler
et al., 2010). An activation layer inserts non-linearity with an activation function
(i.e. ReLU, tanh, and sigmoid) which helps to mitigate the vanishing gradient problem
which prevents updating the weights in training. The purpose of a pooling layer is
to map arbitrary sized inputs to a fixed size representation and hence also to reduce
the number of parameters and computational cost of the model.
The CNN architecture serves as the main inspiration for Graph Convolutional
Neural Networks (GCN). The GCN architectures admit graph structures (in our
case, SemMedDB knowledge graph) in a similar way in the manner that a usual
CNN model takes images as input.
e1
e2
e3
e4 e5
e′1
Figure 2.3: The graph convolutional networks illustration
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2.2.4 Graph Convolutional Neural Networks
Traditional CNNs convolve over a matrix of pixels (representing the image) by fixed
rectangular convolutional filters, while the GCN model uses independent convolution
filters for each entity depending upon the number of neighbors of the entities in the
input graph as illustrated in Figure 2.3 by Veličković et al. (2018). Technically, the
convolution operation will sum all the neighboring node embeddings for both incom-
ing and outgoing edges for every single relation that associates with the corresponding
node as formulated in in the Eq. 2.1.
e
(l+1)
i = σ
(
W
(l)
0 e
(l)
i +
∑
r∈R
∑
j∈N ri
1
cri
W(l)r e
(l)
j
)
(2.1)
where σ(x) represents a non-linear activation function (can be a rectified linear unit
(ReLU)), cri is a normalization constant (showing the number of neighbors via the
corresponding relation r), eli ∈ Rd indicates the latent information of node vi after
l iterations, N ri shows the set of neighbors with relation r ∈ R while W
(l)
r stands
for the weight matrix depending upon the relation r and W(l)0 indicates a single self-
connection to each node in the graph (to retain some of its information from the
previous iteration during current update).
2.3 Evaluation Metrics
The commonly used evaluation metrics in the ML applications are precision, recall
and F-score. These metrics are computed scores from a confusion matrix which
contains the actual true classes and the predicted classes by a classifier (Provost and
Kohavi, 1998). In this dissertation, precision, recall and F-score measures are used
as performance evaluation metrics. Each measure is defined as
P (mi) =
TPi
TPi + FPi
, R(mi) =
TPi
TPi + FNi
, and F (mi) =
2P (mi)R(mi)
P (mi) +R(mi)
,
where TP i, FP i, and FN i are true positives, false positives and false negatives
for the model mi respectively. Here, precision is the ratio of correct prediction of
positive test examples among all test examples predicted as positive, while recall is
the fraction of predicted relevant test examples among all relevant test examples.
F-score is the harmonic mean of precision and recall measures. This score takes both
false positives and false negatives into account and provides a single valued estimate
for the performance of a classification model.
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2.4 System and Environment Details
Experiments in this dissertation were all conducted on Linux servers with the follow-
ing configurations for specific efforts in the .
• Machine name: ubuntuDELVE [Chapter 3]
– Operating system: Ubuntu 14.04.6
– CPU(s): 64, AMD, AuthenticAMD, 2.8 GHz
– RAM: 500 GB
– Storage: 1.1 TB
• Machine name: kyric155 [Chapters 4 and 5]
– Operating system: Ubuntu 16.04.6
– CPU(s): 80, Intel, Xeon E7-4820, 2.0 GHz
– RAM: 3 TB
– Storage: 14 TB
• Machine name: gpu02 [Chapter 5]
– Operating system: Ubuntu 16.04.6
– CPU(s): 40, Intel, Xeon E5-2630, 2.2 GHz
– RAM: 125 GB
– Storage: 6 TB
– GPU(s):
∗ NVIDIA GM200 GTX TITAN X, 12 GB
∗ NVIDIA GM200 GTX TITAN X, 12 GB
∗ NVIDIA GP102 TITAN X (Pascal), 12 GB
∗ NVIDIA GP102 TITAN X (Pascal), 12 GB
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Chapter 3 Exploiting Semantic Patterns over Biomedical Knowledge
Graphs
In this chapter, we describe a new approach for identifying plausible unknown treat-
ment and causative relations by utilizing the graph pattern features and their extrac-
tion. Our basic intuition is simple: different entity pairs participating in a particular
relation type (that is, linked via a specific predicate) are potentially connected in
“similar” ways to each other where the connections are paths between them in knowl-
edge graphs extracted from scientific literature. This is analogous to the NLP variant
where a particular type of relation manifests with certain lexico-syntactic patterns
surrounding the entity pair mentions in free text, the central idea exploited in distant
supervision. In our approach, we need two essential components:
1. a broad scoped and large knowledge graph over which paths connecting candi-
date entity pairs can be obtained and
2. an approach to identify similar paths connecting entities, so we can abstract
or “lift” specific paths to high level semantic graph patterns to be subsequently
used as features in a supervised classifier.
3.1 SemMedDB Knowledge Graph
We build a large knowledge graph of relations obtained from SemMedDB (Kilicoglu
et al., 2012; National Library of Medicine, 2016), a large database of (subject, pred-
icate, object) relationships extracted from biomedical citations (titles & abstracts).
SemMedDB is a public resource made available by the National Library of Medicine
(NLM), which uses their NLP tool SemRep (National Library of Medicine, 2013;
Rindflesch and Fiszman, 2003) to extract “semantic predications” from biomedi-
cal text. SemMedDB is produced by running SemRep on all biomedical citations
made available thorough the PubMed search system. The relations recorded in this
database are called semantic predications given SemRep normalizes textual mentions
of entities to unique UMLS Metathesaurus concepts (that is, performs named entity
recognition) and the predicates are also based upon those available in the UMLS se-
mantic network (National Library of Medicine, 2003a). Each of the UMLS concepts
also has at least one semantic type (National Library of Medicine, 2003b), which is
essentially a classification system to categorize different biomedical entities. As such,
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the relations in SemMedDB represent a semantic summary of biomedical citations
currently indexed by the PubMed search system. Our knowledge graph is essentially
a directed graph with labeled edges formed from the relations in SemMedDB. The
scope of this graph is very broad in a thematic sense given its edges are not limited
to a particular biomedical topic. It is also large in that it has 14.3 million unique
edges∗ connecting over 3 million nodes. It has already been used for literature based
discovery and analysis of clinical documents (Cameron et al., 2013; Cameron et al.,
2015a; Liu et al., 2012; Zhang et al., 2014b; Zhang et al., 2014c).
3.2 Specific Paths & Semantic Patterns
To abstract specific paths between entities over the SemMedDB graph to semantic
patterns, we exploit an intuitive heuristic – simply replace the concepts along the
path with their corresponding semantic type sets (given a concept can have more
than one type) and retain the directions of the edges and edge labels as they are.
For example, consider a sample graph showing a couple of paths between the drug
Lexapro (L)† and the condition major depressive disorder (MDD) in Figure 3.1.
We only employ simple paths (that is, without cycles) and ignore directionality when
computing paths (but retaining it after paths are identified). Thus, we have the
following two paths between L and MDD: (L, ingredient_of−1, E, is_a, SUI, treats,
MDD) and (L, ingredient_of−1, E, treats, ND, treats−1, SUI, treats, MDD), where the
intermediate nodes are Escitalopram (E), Serotonin Uptake Inhibitors (SUI),
and Nonulcer Dyspepsia (ND).
Figure 3.1: A sample graph of biomedical relations
∗Although SemMedDB (Ver. 22) has over 63 million relations, there are many duplicates given
a relation can be extracted from multiple sentences due to the semantic mapping to UMLS concepts
and semantic network predicates.
†Lexapro is the drug brand name of Escitalopram. Even though they are equivalent in pharma-
cology, we might say Lexapro has Escitalopram as an ingredient.
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For notational convenience we encode the reverse direction with a superscript of
−1 on the predicate. To obtain the patterns, we replace the specific entities with
their semantic type sets. Thus, the corresponding two patterns are
(ingredient_of−1, {oc, ps}, is_a, {ps}, treats) (3.1)
and
(ingredient_of−1, {oc, ps}, treats, {f}, treats−1, {ps}, treats), (3.2)
where oc, ps, and f are abbreviations of the semantic types organic chemical, phar-
macologic substance, and finding respectively. A pattern of length l (i.e., based on
a path of length l) has l predicates and l − 1 semantic types in the representation
we use for this effort as shown in these examples (equations 3.1 and 3.2). Note that
patterns do not include the entities being connected, but only the semantic types
of the intermediate notes and the predicates along the path. By replacing specific
intermediate entities with their semantic types we aim to capture high level patterns
that connect candidate entity pairs. Although we just showed two paths, there are
usually many others with a variety of edge types (over 50 different predicates) con-
necting related entities. We reiterate that our main hypothesis is that these patterns
will act as highly discriminative features in identifying entity pairs that participate
in a particular type of relationship. Here we clarify that although we refer to the
SemMedDB graph as a knowledge graph (for general understanding), the precision of
NLM’s SemRep tool used to build SemMedDB is known to be around 75% (Kilicoglu
et al., 2012). However, the advantage of our approach is that our prediction is not
directly dependent on the correctness of each and every relation in the knowledge
graph, rather on the general patterns found within it. Hence, any knowledge graph
with reasonable quality will suffice although high quality graphs should yield bet-
ter results. This was also observed to be the case by Cohen et al. (2014) in their
distributional semantics framework.
For extraction of the paths from the knowledge graph, from our literature review,
there are no efficient implementations for computing all simple paths of an arbitrary
length between two given nodes in large graphs, although many well known algo-
rithms (e.g., modified breadth first search) exist for identifying shortest paths. In
general, finding all simple paths becomes extremely expensive with lengths greater
than three simply because the number of such paths could increase drastically in dense
graphs. Our implementation for lengths ≤ 3 is based on straightforward heuristics
that maintain precomputed lists of neighbors for each node in the knowledge graph.
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Specifically, to determine length two paths between nodes e1 and e2, we simply look
at nodes in N (e1) ∩ N (e2) where N (e) denotes neighbors of node e. To identify
length three paths, we look for edge membership for pairs in N (e1) × N (e2) in our
knowledge graph.
In this effort, we are exclusively interested in predicting treatment/causative re-
lationships and hence we chose this particular example for treats predicate from Fig-
ure 3.1. The two example patterns we show here have a nice high level meaning.
In the first pattern, we see that a pharmacologic substance (SUI) is a hypernym for
another (E) (whose main ingredient is the source (L)) and is known to treat a dys-
function (MDD). The second pattern is similar except that it has two pharmacologic
substances (SUI and E) both treating a common second condition (ND) while one
of them (SUI) treats the target condition (MDD) and the source (L) is the ingredi-
ent of the other. However, in general, the patterns themselves do not need to have
interesting or meaningful interpretations, but when considered together they should
be reasonably predictive of the particular predicate that is of interest to us. In this
specific example, it turns out that the treatment relationship also holds for our can-
didate pair (L, MDD). Essentially, we expect to leverage machine learned models to
automatically weight different patterns based on their predictive power rather than
human experts having to manually identify interesting patterns, a highly impractical
task with the explosion of biomedical knowledge.
We summarize the contributions of this chapter below:
• We propose a novel and intuitive graph pattern feature based approach to pre-
dict treatment and causative relations between any given pair of biomedical
entities using logistic regression (LR) and decision tree models,
• We discuss and present details about the potential of graph patterns in terms
of coverage and utility of top patterns identified through coefficients of our best
LR model,
• Based on inputs from practicing physicians, we analyze false positives with high
probability estimates output by our model to assess their expert based ground
truth labels. We also assess the abilities of our best models to recall treatment
relations from an external drug repositioning dataset.
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Figure 3.2: An example of primitive patterns generated from a compound pattern
(from Eq (3.1))
3.3 Primitive Semantic Type Patterns
Henceforth we call the patterns discussed in Section 3.2 compound type patterns given
an entity is replaced with the set of all semantic types assigned to it. However, there is
a different way to look at semantic patterns where we split these compound patterns
into potentially multiple primitive patterns to generate simpler and more generic pat-
terns. In order to generate primitive patterns, we replace each set of types for the
nodes in the compound pattern with just one of the constituent semantic types. Thus,
we derive primitive patterns from the compound patterns simply by considering all
possible combinations of constituent semantic types for each entity in the compound
patterns. If we consider the first pattern in equation (3.1) as an example, the derived
two primitive patterns will be as in Figure 3.2. So for a compound pattern of length
l, the number of corresponding primitive patterns is
∏l−1
i=1 |S(ei)|, where ei are inter-
mediate nodes along the path and S(e) denotes the set of semantic types for entity e
in the UMLS. Entities joined by the original compound pattern are now considered to
be connected by all the primitive patterns generated from it. The primitive patterns
form a more generic feature space when compared with their compound counterparts.
Complexity & Running Time Details: Finding all possible paths connecting
two entities on our knowledge graph is O(tk) where t is the average number of neigh-
bors and k is the desired path length between a given pair of entities. In order to
generate our features, we have to extract the paths for each of the training instances
and convert them to semantic patterns. To test a pair of entities, we again need the
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extracted patterns between the entities of a given test pair. In our study, we have
totally 7,000 and 2,918 pairs for treats and causes relations, respectively. For these
9,918 pairs (including training & testing), the total extraction time of the patterns
was nearly two weeks.
3.4 Datasets for treats and causes Predicates
In this section we outline how we chose positive and negative examples to build the
two datasets for experiments with graph pattern features introduced in Chapter 3.
3.4.1 Positive Examples from the Metathesaurus
We derive our positive examples dataset from the UMLS Metathesaurus’s MRREL
table (National Library of Medicine, 2009) that has over 26 million manually curated
relations that are sourced from different biomedical terminologies. Among these we
also have several treats and causes relations which are used for our experiments. We
needed an external human vetted resource like the relations in UMLS given our knowl-
edge graph is derived from a computationally curated relation database. We curated
a set of around 7,000 unique treatment relations (entity pairs connected through the
treats predicate) and 2,918 unique causative relations (entity pairs connected through
the causes predicate) connecting UMLS concepts from the MRREL table. For each
predicate, we divided positive example datasets into 80% (5,600 for treats and 2,334
for causes) forming the training set and 20% (1,400 for treats and 584 for causes)
constituting the test set split. Although there were more positive examples in MR-
REL, these counts are based on pairs that had at least one path connecting them in
the SemMedDB graph. This is necessary given we cannot make any prediction (given
there is no information) if the entities are not connected in the graph from which we
plan to extract patterns.
3.4.2 Selection of Negative Examples
Considering concerns identified in Chapter 2 to select negative examples for distant
supervision we carefully choose negative examples in our dataset using the following
two steps.
1. Every predicate in the UMLS semantic network, including treats and causes,
has a set of domain/range semantic type constraints. That is, based on expert
consultation NLM prescribes which types of entities can take the role of the
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subject and object for each relation. All such possible and allowable subject-
object semantic entity type combinations for each predicate are available in
three tables with the SRSTR prefix (National Library of Medicine, 2009) in the
UMLS. We first randomly select a pair of entities (from over 3 million unique
UMLS concepts) that satisfies these domain/range constraints for the predicate
for which we want to build the pattern based model.
2. For each pair selected in step 1, we check to see if the pair is connected via
the predicate of interest to us either in the UMLS MRREL table or in the
SemMedDB relation database. If it does not already occur in our knowledge
bases, we include it as a negative example in our dataset.
This two-step process selects fairly hard-to-classify negative examples since they
satisfy the domain/range constraints but do not participate in a relationship repre-
sented by the predicate for which we want to built the model. Checking for member-
ship in both the UMLS and SemMedDB resources minimizes concerns surrounding
incomplete knowledge bases. Since we want to predict treatment (causative) relations
based on graph patterns, if the knowledge graph already has a treats (causes) edge
between our candidate pairs, the prediction could become trivial and the whole pro-
cess would be self-deceiving. Therefore, we deleted any existing treats (causes) edges
between entities in all training/test positive pairs from the knowledge graph (note
that negative example selection already ensures this) to guarantee a fair analysis of
the predictive ability of graph patterns.
3.5 Experiments and Results
Elaborate experimentation is essential to identify performance trends across different
aspects of our relation prediction problem including dataset constitution and model
features and parameters. In this section we first outline some experimental configura-
tion basics before moving on to specific models built for this effort. We start with the
LR model and build upon its findings to experiment with decision tree (DT) models.
3.5.1 LR Model Configurations and Findings
We use the well known LR algorithm to predict whether an input pair of entities
participates in treatment or causative relationship by building two separate binary
classification models. When the number of features is much larger than the training
instances, LR or support vector machine (SVM) with linear kernels are typically used.
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However, SVMs do not have a straightforward probabilistic interpretation and the ad
hoc means typically used to convert SVM scores to probability estimates are known to
yield results that are not well calibrated (Murphy, 2012, Section 14.5). Furthermore,
the coefficients of features in an LR model are estimates of log odds ratios for the
corresponding features (Kleinbaum and Klein, 2010) and hence such a model lends
itself to straightforward interpretation. Thus, we only use LR models in our effort.
The features for the LR models are frequencies of patterns connecting the input
entity pair as discussed in the beginning of this chapter. The specific implementation
used is the LR classifier based on the LIBLINEAR formulation made available through
the Python scikit-learn (Pedregosa et al., 2011) machine learning library. Parameter
tuning for the regularization coefficient in the LR model did not yield any noticeable
gains and hence we chose to leave it at C = 1, the default value in scikit-learn.
Performances assessment in this effort are based on standard measures of precision,
recall, and F-score. All experiments were repeated using hundred distinct 80%-
20% train-test splits of the full dataset so as to account for chance and to derive
average scores and confidence intervals.
In our earlier effort (Bakal and Kavuluru, 2015), we experimented with a bal-
anced training dataset (equal number of positive and negative instances) considering
imbalanced scenarios for our test dataset. In the universe of all pairs of entities that
satisfy domain/range constraints for a predicate, most are going to be false. For
treats, an arbitrary drug-disease pair would not have a treatment relationship. So we
increased the numbers of negative examples in the test to double that of the positive
examples. We extended this imbalance with positive : negative ratios of 1:5 and 1:10.
With a balanced training dataset, the performance gradually decreased as the test
set imbalance increased. We kept the training dataset balanced to ensure that there
is enough signal for the model to learn patterns for positive instances. This style of
oversampling of the positive class is not uncommon in these cases where the class we
care about is a rare one. In our preliminary results the performance also increased
with the length of the patterns. That is, considering all patterns of length ≤ 3 re-
sulted in better F-score when compared with considering patterns of length ≤ 2 or
one.
In the experiments, we always keep the 1:10 imbalance in the test set given large
imbalance is inherent to the true distribution for treats/causes. We then experiment
with various imbalance scenarios in the training dataset. This is to see whether in-
creasing the number of negative instances in the training dataset would result in
performance gains on the imbalanced test dataset. The negative examples are chosen
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Figure 3.3: Schematic of graph pattern based relation prediction
as discussed in Section 3.4.2. The full dataset size depends on the training dataset
imbalance selected. For example, for the balanced training dataset and 1:10 imbal-
anced test set scenario, for the treats predicate, we have 7000 positive examples (5600
for training, 1400 for test) and 19,600 negative examples (5600 for training, 14,000 for
test). When the imbalance is 1:10 in both training and test datasets, the correspond-
ing counts are 7000 positive examples (5600 for training, 1400 for test) and 70,000
negative examples (56,000 for training, 14,000 for test). Note that these count con-
figurations are limited by the number of positive examples available (Section 3.4.1).
Another parameter to select is the number of patterns to be included in the
feature space. When classifying text with word n-gram features, researchers typically
ignore all n-grams whose frequency is less than a small threshold (mostly set to five).
That is, all n-grams that occurred in fewer than five documents (regardless of class
membership) are ignored in populating feature vectors. We have a similar situation
here with an overwhelming number of patterns of length <= 3 connecting entities
that have a treats or causes relation. We had over 50 million unique compound
patterns for treats and nearly 25 million such patterns for the causes dataset. To
reduce noise and address computational efficacy concerns, we chose those patterns
that occurred as connectives for at least 500 entity pairs for treats and 100 pairs for
causes in the corresponding datasets. This rendered the feature spaces to manageable
sizes of around 600,000 unique patterns for treats and 200,000 for causes.
The overall architecture of our method is shown in Figure 3.3. Although we are
currently discussing LR models, any supervised learning algorithm can be used with
graph pattern based features.
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3.5.1.1 Balanced Training Dataset Scenario
As we mentioned earlier in this section, the balanced models have equal number
of positive and negative examples in training dataset; the test set always has ten
times as many negative examples as the positive ones to model realistic scenarios. In
Table 3.1, we show the average precision, recall, and F-scores computed over hundred
distinct splits of the full dataset for treats. The performance gains between the 1000
and 500 pattern frequency thresholds are not substantial. We see a precision gain of
around 4% and a recall loss of 0.3% for each threshold when using primitive patterns
over compound patterns.
Table 3.1: Balanced training data: test set scores with patterns of length ≤ 3 for
treatment relations
Pattern Type
Min. Frequency: 1000 Min. Frequency: 500
Precision Recall F-score Precision Recall F-score
Compound 0.675 0.926 0.781 0.683 0.928 0.786
Primitive 0.717 0.924 0.807 0.721 0.925 0.810
Performances when using primitive patterns are also superior for causes as shown
in Table 3.2 except for the higher pattern frequency threshold of 1000. The actual
F-scores are lower for causative relations when compared with treatment relations.
The 95% confidence intervals we computed for F-scores have widths ≈ 0.01 when
using primitive and compound patterns; thus they do not overlap for both predicates.
Thus overall, primitive patterns are more effective for the balanced training dataset
scenarios.
Table 3.2: Balanced training data: test set scores with patterns of length ≤ 3 for
causative relations
Pattern Type
Min. Frequency: 1000 Min. Frequency: 500 Min. Frequency: 100
Prec. Rec. F-score Prec. Rec. F-score Prec. Rec. F-score
Compound 0.446 0.744 0.554 0.472 0.776 0.583 0.478 0.811 0.598
Primitive 0.400 0.736 0.518 0.510 0.756 0.609 0.546 0.791 0.645
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3.5.1.2 Imbalanced Training Dataset Scenarios
While keeping the 1:10 positive to negative class test imbalance, we wanted to see
the effect of increasing the imbalance in the training dataset in contrast with the
scenario in Section 3.5.1.1. From Tables 3.3 and 3.4, we notice that the imbalance
setting where |N | = 10 · |P | in training datasets gives the best overall F-score when
compared with situations with less imbalance (including in comparison with top scores
in Tables 3.1 and 3.2).
Table 3.3: Imbalanced training data: test set scores with length ≤ 3 compound
patterns for treatment relations
Imbalance in
training set
Min. Frequency: 1000 Min. Frequency: 500
Prec. Rec. F-score Prec. Rec. F-score
|N | = 2 · |P | 0.979 0.962 0.970 0.981 0.964 0.973
|N | = 4 · |P | 0.988 0.964 0.976 0.988 0.966 0.977
|N | = 10 · |P | 0.992 0.966 0.979 0.992 0.968 0.980
Furthermore, the 95% confidence interval widths for the top F-scores in Tables 3.3
and 3.4 are very small – 0.0011 (for treats) and 0.0036 (for causes). The improve-
ments are not as substantial for treats but are prominent for causes when training set
imbalance is increased; for the latter predicate, however, the recall goes down with
increase in training set imbalance which is compensated by an increase in precision
leading to an overall better F-score. Lowering the minimum pattern frequency yields
marginal improvements for treats compared with corresponding gains for causes. Note
that our improvements in Tables 3.3 and 3.4 with imbalanced training datasets are
using compound patterns.
Table 3.4: Imbalanced training data: test set scores with length ≤ 3 compound
patterns for causative relations
Imbalance in
training set
Min. Frequency: 1000 Min. Frequency: 500 Min. Frequency: 100
Prec. Rec. F-score Prec. Rec. F-score Prec. Rec. F-score
|N | = 2 · |P | 0.744 0.724 0.732 0.868 0.775 0.819 0.865 0.846 0.855
|N | = 4 · |P | 0.851 0.698 0.766 0.922 0.760 0.833 0.924 0.837 0.878
|N | = 10 · |P | 0.950 0.646 0.769 0.967 0.745 0.842 0.967 0.816 0.885
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Contrary to our observations in balanced training dataset scenarios as we men-
tioned in Section 3.5.1.1, we noticed that compound patterns provided major gains
over primitive patterns for the imbalanced scenarios. Furthermore, the number of pat-
terns is substantially higher for primitive patterns (at least twice as many) leading to
additional efficiency concerns. We show our observations for causes in Table 3.5 when
using primitive patterns. When comparing these scores with those in Table 3.4, it is
clear that compound patterns are better overall in imbalanced training dataset cases,
which offer the best case for improving test score performances. The 95% confidence
intervals we computed for F-measures in the last row and last column in Tables 3.4
and 3.5 have widths < 0.01 and hence do not overlap. Thus the improvements with
compound patterns are statistically significant. Although we do not show the results
here, we observed a similar trend with compound patterns outperforming primitive
patterns when considering patterns of length ≤ 2 for both treats and causes. We
believe this reversal in performance trend for primitive patterns is due to the fact
that imbalanced training datasets lead to an explosion of unique patterns from the
negative examples. When this happens, the generic and simpler primitive patterns
may lose their discriminative power in comparison with the more specific compound
patterns.
Table 3.5: Imbalanced training data: test set scores with length ≤ 3 primitive pat-
terns for causative relations
Imbalance in
training set
Min. Frequency: 1000 Min. Frequency: 500 Min. Frequency: 100
Prec. Rec. F-score Prec. Rec. F-score Prec. Rec. F-score
|N | = 2 · |P | 0.531 0.685 0.597 0.626 0.710 0.665 0.667 0.728 0.696
|N | = 4 · |P | 0.619 0.667 0.642 0.721 0.684 0.702 0.761 0.689 0.723
|N | = 10 · |P | 0.762 0.597 0.669 0.799 0.623 0.700 0.817 0.621 0.705
Note that imbalanced training datasets improve precision even though we add
more negative examples because the test set has always had a fixed ratio of 10:1
for negative to positive example counts. Hence a training dataset with a balanced
distribution of classes will typically result in a model that will predict more instances
as positive in the test set, which decreases precision. But as the training dataset im-
balance is increased, the model has more negative examples to identify discriminative
features and hence is trained to incur fewer FPs. This leads to increased precision.
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3.5.2 Experiments with Decision Trees
In Section 3.5.1, we exclusively studied application of logistic regression models to
predict relations. In this section, we discuss additional experiments we conducted
with decision trees (Breiman et al., 1984) to explore nonlinear models that are also
interpretable. We use the same approach as in Section 3.5.1 to come up with average
scores over hundred distinct runs with 80% used for training and 20% for testing. Our
results are shown in Table 3.6 for the imbalanced training dataset scenario with 1:10
imbalance in the test set (given this turned out to be the best configuration based
on results from Tables 3.3 and 3.4). Given deeper trees can model more complex
relationships by trading off interpretability, we experimented with scenarios where
the maximum depth is restricted to five and when it is left unconstrained. As can
be noticed from the table, the recall is much better when depth is not constrained.
The scores are also slightly better than the best results obtained through LR models
(from Tables 3.3 and 3.4).
Table 3.6: Imbalanced training data: average test set scores using decision trees with
compound patterns
Predicate type
Max depth = 5 No depth constraint
Precision Recall F-score Precision Recall F-score
Treats 0.998 0.815 0.897 0.994 0.987 0.990
Causes 0.994 0.506 0.669 0.922 0.887 0.904
3.5.3 Recall Analysis Using an External Dataset: repoDB
Our experiments reported thus far involved positive relations that are well known
and recorded in the UMLS. Although our performance scores reported are on held-
out datasets, it is possible that patterns connecting well known relations may not
be present in newly discovered relations. repoDB (Brown and Patel, 2017) is a
database that has over 6,000 Food and Drug Administration (FDA) approved drugs
and corresponding indications collected from the regularly updated DrugCentral plat-
form (Ursu et al., 2017). As such repoDB is expected to contain the latest FDA
approved drugs. To test our best (both LR and decision tree) models,
1. We removed UMLS treatment relations from the list of all FDA approved drug-
disease indications from repoDB.
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2. We also removed relations whose entities are already connected through a treats
edge in SemMedDB.
3. Out of the remaining approved drug-disease relations, we removed those that do
not have at least one path connecting the involved entities in the SemMedDB
graph from which we derived our patterns.
Table 3.7: Balanced training data: average recall on repoDB with graph patterns
Model Compound Primitive
LR 18.6% 43.1%
Decision tree 52.9% 50.7%
After these filtering processes, we were left with 2739 new treatment relations. We
built 100 different models for the treats predicate based on positive examples used
in Sections 3.5.1 and 3.5.2 with a fresh set of negative examples chosen for each of
the models. Next, we computed the average recall by running them on these 2,739
instances we obtained from repoDB. Our results shown in Table 3.7 indicate that we
are able to recall over 50% of the approved drugs that are at least connected with
one path in SemMedDB. Decision trees (without max depth constraints) proved to
be much better than LR models. Primitive patterns seems to help LR models while
both types of patterns resulted in similar performances when using decision trees.
Using imbalanced training data that gave us over 95% F-scores for held-out UMLS
treatment relations turned out to be ineffective to retrieve repoDB relations. Under-
sampling the majority class when the minority class is of high relevance is a tested
method (Wallace et al., 2011) and appears to work well for our situation too.
3.5.4 Validation of SemmedDB Knowledge Graph & Semantic Patterns
As we mentioned in Section 3.4.2, the precision of the SemMedDB knowledge graph
is around 75%; therefore, we would like to demonstrate the usefulness of both the
SemMedDB graph and our research idea in an alternative way of validation. In order
to validate SemMedDb and show its predictive power, we pick 1,000 pairs that have at
least five times direct TREATS and CAUSES relations between them for treats and
causes predicates separately. Once we select the pairs, then we remove them from the
original SemMedDB graph so that we will have new graphs where direct relations are
not present between the pairs for each predicate. With the new knowledge graphs, we
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generate semantic patterns of the pairs to subject them to our 100 predictive models
(with primitive semantic patterns) to obtain the accuracy even without the direct
connection. The results we obtain for both treats and causes predicates are below.
Table 3.8: Validation of the SemMedDB graph with graph patterns
Predicates Precision Recall F-Score
Treats 1 0.897 0.945
Causes 1 0.773 0.871
When we analyze the results as shown in Table 3.8, we can simply see that preci-
sion is 1 for each predicate because we are deliberately using only positive instances
without direct relations between the pairs. Therefore, due to the absence of any FP
instances, the precision stays 1. However, there are also highly predictive negative in-
stances (selection process expressed in Section 3.4.2) in the training data. Hence, we
have some FN instances as output which give rise to moderately lower recall scores.
When we look at the F-Score column, the confidence intervals for treats predicate
are (0.94 ± 0.002) while the confidence intervals for causes are 0.871 ± 0.005. The
reason of partially lower scores for causes is that we have less number of pairs than
treats predicate to encode more indicative paths & patterns. Eventually, these results
demonstrate that SemMedDB is a useful knowledge source even though its precision
is not perfect.
3.6 Qualitative Analyses of LR Models: Informative patterns and new
hypotheses
In Section 3.5, we focused exclusively on quantitative evaluation of our methods and
showed that best results are obtained by using compound patterns and imbalanced
training datasets for both predicates. But it is also important to analyze the patterns
qualitatively in terms of their discriminative power and their suitability in discovering
previously unknown relations.
3.6.1 Exploring Highly Discriminative Patterns
In order to assess the predictive contribution of different graph pattern features, we
conducted an additional experiment to identify patterns that correlate well with pos-
itive examples. During the process of building hundred different models based on
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hundred distinct 80%-20% train-test splits of the full datasets, we stored model co-
efficients for all features. Subsequently, we ranked all patterns based on the average
coefficient value across the hundred models. If β is the model coefficient of a pattern
in the LR model, we know eβ is the odds ratio of that pattern with respect to the pos-
itive class (Kleinbaum and Klein, 2010). Hence, ranking patterns in the descending
order of the corresponding average model coefficient values is equivalent to ranking
them based on their importance toward the positive prediction for the corresponding
predicate. Thus we ranked all patterns accordingly and made them available as sup-
plementary materials along with this manuscript. The patterns can also be searched
and visualized using an online interface: http://patterns.mgokhanbakal.net/. In or-
der to assess the sensitivity of the top patterns, we considered the top hundred pat-
terns selected as per this ranking. For treats, the top 100 patterns cover 43% of the
7,000 instances. For causes, the top 100 connected 25% of the full positive instance
dataset. This indicates that our method is able to identify high quality patterns that
can be used to query knowledge graphs for generating potential new hypotheses.
Figure 3.4: Example discriminative treats patterns obtained through our methods
Another objective is to manually examine these patterns and see if they are mean-
ingful or informative in some sense. We show some interesting patterns in Figure 3.4
from our full pattern list for treats predicate. Patterns P1–P4 are those obtained from
the top 100 patterns among nearly 600,000 unique patterns ranked. P1 indicates the
situation where two drugs treat a common condition (node 2) and given one of them
(node 3) treats our target condition, it is also plausible for our source substance to
treat the target. P2 has a similar structure except we have a common therapeutic pro-
cedure that uses the two medications (a source and another intermediate antibiotic).
P3 involves the patient group semantic type (e.g., cancer patients) that is connected
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to a condition via the process-of predicate. It also uses a class membership relation
as the first edge to form a meaningful pattern connecting the instance of a class of
drugs to a target condition affecting a patient group. P4 involves two conditions
(an intermediate one and the target condition) that share an immunologic factor and
the pattern connects the source to the target via a treatment relation involving the
intermediate condition. Thus we see that patterns identified through our approach
appear to have an intuitive semantic interpretation.
Patterns P5–P8 are also high scoring patterns that appeared in the top 1% of the
full ranked list. We show them in the figure given a recent effort by (Cohen et al.,
2014) also identified them as top scoring reasoning pathways for cancer therapies. In
fact, all pathways identified by them show up in the top 1% of our ranked pattern list.
We do not show the semantic types of intermediate nodes given Cohen et al. do not
consider types as part of their reasoning pathways. Hence, each of their pathways can
match multiple patterns in our list; hence, we show counts of our unique patterns (or
unique type combinations) that match the corresponding pathway in parentheses next
to the ID for P5–P8 in Figure 3.4. However, as we pointed out in Chapter 2, Cohen
et al.’s work takes a retrieval approach to surface a few top patterns, while we focus
on building a high accuracy predictive probabilistic model that is also interpretable
through its feature coefficients.
One interesting observation here is that most of the patterns for treatment rela-
tions shown in Figure 3.4 have a treats edge in them. In fact, among the top 1000
treatment (causative) relation patterns 646 (241) contain a treats (causes) edge. This
is not surprising for treatment relations given certain drugs and procedures treat clus-
ters of diseases that share certain characteristics. Thus, even though the predicted
relation may not be there in the SemMedDB graph, other treatment relations involv-
ing the subject medication might be indicative of its therapeutic potential for the
target condition. Intuitively, this also conveys the general motivation behind compu-
tational drug repurposing efforts that are popular these days (Andronis et al., 2011;
Li et al., 2016; Xu et al., 2014). Another aspect of note is that most top patterns are
of length three. Of the top 10,000 patterns for each predicate, the count of length two
patterns is only 24 for treats and 47 for causes. This might simply be because of the
fact that, in general, paths of length three are much more common than length two
associations in SemMedDB. Hence length three patterns offer a much larger feature
space to exploit for our predictive models.
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3.6.2 Discovering New Relations
Our evaluations thus far focused on hand curated relations already recorded in the
UMLS or repoDB. However, we thought it would be more interesting to see if our
approach can discover new plausible relations that are not already known. From
Sections 3.5.1.2 and 3.5.2, it is clear that our approach achieves very high precision
for both treatment and causative relations. However, we still have some false positives
(FPs). The intuition is that high scoring FPs could actually be plausible new relations
that are not already known to the medical community. To this end, we chose 10,000
new negative examples for treats and causes that are not part of the negative examples
chosen to be in our training datasets used in Section 3.5 and the additional examples
used in this section. We built 100 different models for each predicate changing only
the negative examples as was done in Section 3.5.3. We applied these hundred models
to each of the 10,000 negative examples chosen for this experiment.
Next, we needed a way to carefully choose high confidence positive predictions
for expert review. For this, we finalized a list of all negative examples that were pre-
dicted as positive by at least 90 models (that is with output probability ≥ 0.5) and
have an average probability estimate of at least 0.9 (overall hundred models). This
process resulted in a total of 181 instances for treats and 138 instances for causes.
These potentially new relations were independently reviewed by two practicing in-
patient physicians (Drs. Talari and Kakani) at the University of Kentucky hospital
for biomedical plausibility. After independent annotations, both physicians resolved
their disagreements. 33% of treats FPs and 28% of the causes FP instances examined
were deemed plausible by the physicians. Thus we are able to identify relations that
are not in our knowledge bases but are still plausible. However, we needed experts to
also assess novelty based on their knowledge. Although these FPs are plausible pos-
itive instances, they could just be common knowledge to experts and are simply not
available in UMLS and SemMedDB. Among the treats instances that were deemed
plausible, 68% were also identified as potentially novel findings by the physicians.
This proportion is only 5.5% for causes ; so most plausible FPs were already known
to the experts despite their absence in our sources.
Among the manually reviewed FP examples, the experts chose a few plausible
and novel examples for each relation (treats and causes) and came up with the corre-
sponding plausibility explanations as follows. This was done to simulate the discovery
process using our approach and offers additional evidence of practical relevance of our
methods.
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Plausibility of new treatment relations identified
1. Gentamicin Sulfate TREATS−−−−−−→ Anthrax disease:
Gentamycin Sulfate is an antibiotic that is used on the outside of the body (topical).
It belongs to aminoglycoside class of antibiotics. It acts by disrupting the normal cycle
of ribosomes, which are the structures present inside a cell. This disrupts initiation
of protein synthesis inside the cells. These antibiotics are directed primarily against
aerobic gram-negative bacilli class of bacteria but have limited activity against gram-
positive class of bacteria. Bacillus Anthracis bacteria causing Anthrax is classified as
gram-positive rod. Cutaneous Anthrax disease can be potentially treated by topical
gentamicin sulfate with the above rationale.
2. Orbifloxacin TREATS−−−−−−→ Dysentery | Infectious Diarrhea:
Orbifloxacin is an antibiotic mainly used in animals. It belongs to fluoroquinolone
class of antibiotics. Fluoroquinolone class of antibiotics are used in human beings for
the treatment of Dysentery and Infectious diarrhea. Orbifloxacin is a fluoroquinolone
antibiotic, so there is a biological plausibility for it be used in human beings for the
treatment of Dysentery and Infectious diarrhea, as the mechanism of action of these
group of drugs is the same.
3. Zorubicin TREATS−−−−−−→ Acute Myelomonocytic Leukemia:
Zorubicin is a medication that belongs to Anthracyclin class of drugs. Anthracyclin
class of drugs are used in the treatment of cancers including leukemia. Therefore, it
is biologically plausible for it to be used in the treatment of acute myelomonocytic
leukemia.
4. Ziconotide TREATS−−−−−−→ Nonspecific Urethritis:
Ziconotide is a synthetic peptide related to the marine snail toxin ω-conotoxin, which
selectively blocks N-type calcium channels at the cellular level. It is used in patients
with chronic pain by injecting this substance into the spinal canal. With this rationale,
this drug can be used to treat pain from Nonspecific urethritis as well through the
same mechanism of action.
5. Miocamycin TREATS−−−−−−→ Staphylococcus Aureus Pneumonia:
Miocamycin is an antibiotic that belongs to Macrolide class antibiotics. Macrolide an-
tibiotics have activity against many classes of bacteria including gram-positive cocci
class of bacteria. Staphylococcus Aureus is a gram-positive cocci class of bacteria.
With this rationale, miacomycin can be used to treat Pneumonia caused by Staphy-
lococcus Aureus bacteria.
32
Plausibility of new causative relations identified
1. Human Metapneumovirus CAUSES−−−−−−→ Systemic Lupus Erythematosus (SLE):
The etiology of SLE is unknown and is probably multifactorial. Interplay of genetic
predisposing factors, environmental factors, and hormonal factors is thought to play
a role. Among environmental factors, various viruses are thought to stimulate the
body’s immune network. For example, people with SLE are known to have high levels
of autoantibodies to Epstein Barr virus and certain retroviruses. Thus the role of
immune response to Human metapneumovirus infection in the etio-pathogenesis of
SLE is a topic that warrants additional exploration.
2. Maternal Fetal Infection Transmission CAUSES−−−−−−→ Autoimmune Diseases:
The etiology of many autoimmune diseases is unknown. During immune development
in the fetus, maturing lymphocytes in thymus and bone marrow are exposed to several
antigens and those immune cells reacting to self-antigens are selectively inactivated via
apoptosis (programmed cell death) or by induction of anergy. Thus the involvement
of fetal infection during gestation with the process of self-antigen recognition is worth
further analysis.
3. Human Herpes Virus 6 CAUSES−−−−−−→ IgG Gammopathy:
Human herpes virus 6 (HHV-6) was first isolated in patients with lymphoprolifera-
tive disorders. HHV-6 infection has been associated with a prolonged mononucleosis
like syndrome with prolonged lymphadenopathy and encephalitis. Associations be-
tween HHV-6 and diseases such as multiple sclerosis and neoplasia have been proposed
but remain unproven. HHV-6 antigens and DNA have reportedly been detected in
some malignant tissues such as lymphomas. Hence HHV-6 may play a role in IgG
gammopathies (increased immunoglobulins belonging to Ig-G class due to abnormal
proliferation of some bone marrow cells) such as Monoclonal gammopathy of uncertain
significance (MGUS) deserving additional attention.
We also wanted to see if we can find examples for some of the high confidence FPs
in literature (in addition to clinician assessments discussed earlier in this section).
For this purpose, we used one of the high confidence FPs which is (Ampicillin, treats,
Ischemic Enteritis). We searched the key phrase as (Ampicillin AND “Ischemic
Enteritis”) on PubMed and found some articles mentioning the treatment connec-
tion between the entities. In this context, one of the articles found was “A Novel
Model of Ischemic Enteritis Induced in Rats by Stenosis of the Superior Mesenteric
Artery”. In this article, the last sentence of the key finding section in the abstract is
“The ischemia-induced enteritis was significantly prevented by repeated treatment
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with aminoguanidine (a selective iNOS inhibitor), L-NAME (a nonselective NOS in-
hibitor), ampicillin, and aztreonam (a gramnegative bacterium antibiotic), but not
vancomycin (a gram-positive bacterium antibiotic)”. Here, the sentence clearly con-
veys ampicillin has a significant role to prevent ischemia-induced enteritis. In this
specific example, we can see that high confidence FPs can also be supported in med-
ical literature.
3.7 Conclusion
Treatment and causative relations are central to knowledge discovery in biomedicine.
In this chapter, we employed semantic graph patterns connecting pairs of candidate
entities as the sole set of features to predict treatment and causative relations between
them. We exploited a well-known biomedical relation database, SemMedDB, to build
a knowledge graph with over 14 million edges extracted from scientific literature. We
then used this graph to derive features and also select suitable negative training in-
stances for predictive modeling experiments. Evidenced by the results presented in
Section 3.5, we have successfully verified our hypothesis that semantic patterns over
knowledge graphs can be powerful predictors of treatment and causative relations.
Specifically in Section 3.5.3 we demonstrated that supervised treats models trained
with graph pattern features can also recall newly approved drugs along with the
corresponding indications from an external dataset. Moreover, we analyzed the top
patterns informed by model coefficients and demonstrated their interpretability for
gaining insights into the prediction process. Additionally, we sought human expert
assessments to demonstrate the utility of the proposed approach in identifying poten-
tially novel and previously unknown relations. Eventually, our results in this effort
demonstrate that semantic patterns over knowledge graphs hold great promise for
global relation prediction in biomedicine.
34
Chapter 4 Non-Negative Matrix Factorization for Drug Repositioning:
Experiments with the repoDB Dataset
Computational methods for drug repositioning are gaining mainstream attention with
the availability of experimental gene expression datasets and manually curated rela-
tional information in knowledge bases. When building repurposing tools, a funda-
mental limitation is the lack of gold standard datasets that contain realistic true
negative examples of drug–disease pairs that were shown to be non-indications. To
address this gap, the repoDB dataset was created in 2017 as a first of its kind re-
alistic resource to benchmark drug repositioning methods — its positive examples
are drawn from FDA approved indications and negatives examples are derived from
failed clinical trials. In this chapter, we present the first effort for repositioning that
directly tests against repoDB instances.
Repositioning previously approved drugs for new indications has become highly
desirable in the biomedical and pharmaceutical research enterprises given expected
time/cost reductions in identifying new treatment options. With recent estimates
putting new drug development R&D costs over $2.5 billion per drug (DiMasi et
al., 2016), repurposing has been gaining mainstream attention over the past five
years. With previously approved drugs already passing the required safety tests
for use in humans, the cost of repositioning is expected to be substantially lower
compared with starting from a blank slate. In 2011, the National Library of Medicine
(NLM) introduced drug repositioning (DR) as a new Medical Subject Heading
(MeSH term) and as of now there are 1,161 articles tagged with it dating back to a
single article from 2009. Almost 85% of these articles are published in the last five
years indicating the sudden and deserved surge of interest in this area. Physicians
with deep understanding of both the mechanisms of action for drugs and disease
characteristics may be able to recommend off-label use (Stafford, 2008) in an ad hoc
manner. However, this does not constitute (FDA) approved recommendation for
specific new indication(s) of drugs for use in designated groups of patients. As such,
DR (via FDA approval) for new indications has significant potential to impact care
at a broad scale and might also result in lowered costs for patients.
Overall, we make the following contributions in this chapter:
• We demonstrate that matrix completion through NMF is a practical way for
computational drug repositioning (CDR) by pruning the large space of drug
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candidates before further analysis.
• We evaluated our NMF models against a gold standard drug repositioning
database, repoDB, and showed that the NMF values of approved and failed
treatments were not overlapping in any configuration.
4.1 Related Work: Computational Drug Repositioning
Computational drug repositioning (Li et al., 2016) (CDR) is the use of informatics
and high performance computing methods to prioritize candidates for new indica-
tions. With the simultaneous excitement surrounding biomedical data science and
the explosive growth of publicly shared datasets, CDR methods are on the rise in
the scientific community. A class of such methods exploits the notion of “similarity”
between different entities involved in disease and therapeutic mechanisms. For ex-
ample, shared traits among drugs including chemical structures, molecular activities,
and side effects may be used to define a feature vector to represent a drug. Likewise,
similarities can also be established between diseases based on established gene–disease
associations or graph based proximity in disease ontologies. Zhang et al. (2014a) pro-
vide a unified framework that exploits these similarities for CDR. Another direction
of CDR is exploiting available large-scale genomic data sources. For instance, Dud-
ley et al. (2011) utilized drug-gene expression signatures to discover a potential new
drug for the inflammatory bowel disease. Topological analyses of drug–target net-
works and target-involved pathways are another mode of identifying potential new
indications (Li and Lu, 2013). Text mining programs that extract different relations
from text using natural language processing (NLP) and literature based discovery
approaches that build on such relations are also being employed for CDR (Andronis
et al., 2011; Cohen et al., 2014). A more detailed treatise of CDR methods is available
in a recent survey (Li et al., 2016).
Although CDR is gaining prominence, evaluating CDR methods can be tricky
given the lack of datasets that are tailored for it. Specifically, from our literature
review we were able to identify very few standardized datasets (Zhang et al., 2014a;
Gottlieb et al., 2011) that are uniformly used across efforts for benchmarking pur-
poses. Furthermore, the datasets used in prior efforts have a serious shortcoming —
they only contain positive drug–disease indication pairs; and hence prior efforts as-
sume that all other combinations are negatives, which is unreasonable and potentially
rules out novel repositioning predictions as false cases. Brown and Patel (Brown and
Patel, 2017) highlight this shortcoming and propose a new gold standard database
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called repoDB for CDR method benchmarking. repoDB draws approved indications
from the DrugCentral (Ursu et al., 2017) database and failed indications from the
American Association of Clinical Trials Database (the ‘AACT Database’ (Tasneem
et al., 2012)), which is a structured version of information from NLM’s ClinicalTri-
als.gov service. Given failed indications are part of the dataset, one can directly
assess CDR methods with vetted indications and non-indications from repoDB. Since
its introduction in 2017, however, we are not aware of any CDR efforts evaluating
against repoDB.
In this effort, we present the first CDR attempt that directly tests against repoDB
instances. First, a partially observed matrix is built using drug–disease treatment
relations drawn from the UMLS Metathesaurus (National Library of Medicine, 2009)
and those extracted using automated NLP methods and made available by the NLM
as part of the SemMedDB database (National Library of Medicine, 2016; Kilicoglu
et al., 2012). Next, this matrix is completed by filling unobserved cells via non-
negative matrix factorization (NMF) to elicit new indications. Our method uses a
small portion of repoDB as validation and uses the bulk of it for testing purposes.
4.2 Datasets
In this section, we describe the data sources from which we derive our training and
testing examples. The UMLS (National Library of Medicine, 2009) and SemMedDB
are our essential data resources for training instances while repoDB is our resource for
the test examples. We use the terms “training” and “testing” to emphasize that this
is still a (weakly) supervised method where the training instances are simply drawn
from external resources both manually curated (UMLS) and automatically extracted
(SemMedDB). We will briefly describe each data source in the following subsections.
4.2.1 UMLS Metathesaurus
UMLS is a longstanding terminological resource that integrates over 160 different
vocabularies updated every year by the NLM. The Metathesaurus portion of UMLS
aggregates equivalent concepts across multiple vocabularies and assigns to each unique
concept a concept unique identifiers (CUI). Besides synonymous names for each con-
cept, there are also inter-concept relations sourced from the original vocabularies.
We obtained treatment relations from the MRREL table∗ in UMLS Metathesaurus
∗Specifically, these are the relations where the RELA field in MRREL table is equal to one of
these four types: “treats”, “may_treat”, “treated_by”, and “may_be_treated_by”
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database (National Library of Medicine, 2009) version 2017AB. A total of 43,898 such
relations are part of our UMLS training dataset.
4.2.2 SemMedDB – Semantic Medline Database
SemMedDB is a repository of (subject, predicate, object) triples called semantic pred-
ications extracted by a rule-based NLP tool SemRep (National Library of Medicine,
2013) developed by the NLM. SemMedDB is built by running SemRep over all avail-
able PubMed citations (over 27 million) where the subject/object entities are normal-
ized to UMLS CUIs. Likewise, the predicate is mapped to a relation type from the
UMLS semantic network (National Library of Medicine, 2003a). Given a predication
can be extracted from multiple sentences, we also have frequency information (number
of unique sentences containing it) for each SemMedDB triple. For our experiments, we
curated treatment predications (triples where predicate = TREATS) in SemMedDB
as additional training examples. As SemRep’s precision is around 75% (Kilicoglu
et al., 2012), we only collected predications which have been extracted at least twice,
thrice, and five times to include them in the training set in various configurations
(more later). Hence, we were able to obtain three different treatment predication sets
of 55,349, 34,802 and 19,777 triples for the frequencies of 2, 3, and 5 respectively as
long as they are not occurring in test sets from repoDB.
4.2.3 The repoDB Database
As indicated in Section 4.1, instances in repoDB come from DrugCentral (Ursu et
al., 2017) and ClinicalTrials.gov (Tasneem et al., 2012) resources. It has a total of
6,677 approved and 3,885 failed drug–disease pairs. After removing the duplicates
and the ones which appear in UMLS (given UMLS pairs will be part of the training
dataset), we were left with 6,218 approved and 2,852 failed pairs. After removing
pairs associated with drugs for which there is not even a single positive pair from
UMLS/SemMedDB, we are left with 5,172 approved treatments (ATs) and 2,244
failed indications (FIs). This aligns with the nature of CDR to some extent — if we
do not even have a single occurrence of a drug treating some disease, we may not be
able to repurpose it for other conditions. This is also an inherent limitation of the
matrix completion method we propose to use; if the row corresponding to a drug in
the drug–disease matrix is empty, matrix completion methods cannot fill that row
and hence it is impossible to come up with new indications for it (more later).
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4.2.4 Generation of Randomly Selected Negative Examples
The repoDB examples are vetted ATs and FIs, identified based on clinical trials. We
also wanted to build a separate dataset of random indications (RIs) which satisfy
domain/range constraints for subjects/objects for treats predicate. The purpose is
to see if our method would have a relatively easier or harder time when dealing with
these when compared with FIs from repoDB. In the past we have generated such a
dataset (Bakal and Kavuluru, 2015) for a slightly different task. Basically, these RI
examples are created by the following steps.
• Each concept in UMLS has at least one semantic type that represents a class
membership. Furthermore, every predicate in the UMLS semantic network has
a set of domain/range semantic type constraints defined by the NLM based on
domain expert knowledge. Based on the allowable semantic type combination
for the treats predicate, we randomly select pairs that satisfy the domain/range
constraints.
• For the set of pairs selected using the previous step, we simply remove the pairs
which appear as treatment relations either in UMLS or SemMedDB. Thus, we
ensure that selected pairs do not occur in our training set.
The given steps above pick fairly hard-to-predict potentially negative examples be-
cause they satisfy the domain/range constraints and are not present in either UMLS
or SemMedDB databases. Ultimately, we obtained 3,318 examples to be used as the
RI test set for the matrix completion methods.
4.3 Methods
In this section we present the NMF based matrix completion method along with our
approach to configure it with different input matrices from external data sources.
4.3.1 Matrix Completion Through NMF
Matrix completion (Jannach et al., 2016) is the process of filling missing entries in a
partially observed matrix. These partially observed matrices arise in many real world
scenarios especially in recommender systems where preferences of people are encoded.
A matrix with customers as rows and and products (e.g., movies, books) as columns
is the typical setup. Given information about their prior ratings or product purchases
represented as 1s in the corresponding cells, matrix completion would identify what
other cells ought to be 1s — which other products would a customer likely enjoy given
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what they already liked. In a completely random world, there is no way to guess the
new 1s. However, assuming the matrix has a much smaller rank thanmin(m,n) for the
m×nmatrix, we can use non-negative matrix factorization (NMF) (Wang and Zhang,
2013) to come up with a low-rank approximation to the original matrix with [0, 1]
non-zero entries in blank cells, leading to potential new recommendations. This low-
rank assumption is based on the intuition that there are latent themes/traits in user
preferences and a typical user’s preferences are not distributed truly randomly across
the product space. A similar strategy is also employed in information retrieval for
latent semantic indexing (Deerwester et al., 1990) for computing document similarity
through dimensionality reduction.
One can now see that the CDR problem can be modeled similarly where the train-
ing treatment relations can be used to partially fill the drug–disease matrix, with NMF
filling empty cells with non-zero values pointing to potential new indications. Since
this is an approximation process, the new values in empty cells will be non-zero but
generally not exactly 1. Thresholding based on a validation dataset can be used to
glean indications if a particular cell’s value crosses the threshold. The intuition here
is also to exploit potential latent themes where groups of drugs sharing certain char-
acteristics (e.g., mechanism of action) may treat clusters of conditions with similar
traits (e.g., symptoms). Given we do not know what the myriad latent themes may
be, we assume a certain number of them are present — the chosen low rank — and
proceed with NMF for matrix completion. Thus, given the partially observed m× n
drug–disease matrix X with m drugs and n diseases, we will approximate it as
X
m×n
≈ W
m×k
× H
k×n
= X̂
m×n
, (4.1)
where W and H are the factors with rows of W representing k-dimensional drug vec-
tors and columns of H encoding k-dimensional disease vectors under the assumption
that X has rank k  min(m,n). The product X̂ = WH approximates X helping
us glean new non-zero values hinting at new indications, while the rows of W and
columns of H can be used to compute drug and disease similarities respectively. The
objective function to find the best approximation is
argmin
W,H
‖X −WH‖+ β(‖W‖2 + ‖H‖2)︸ ︷︷ ︸
regularization
, (4.2)
where W ∈ Rm×k+ and H ∈ Rk×n+ and β is the weight for the regularization penalty
term to handle overfitting that corresponds to large norms for W and H. Next, the
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Figure 4.1: Schematic summary of the proposed NMF based CDR experiments
construction of the input drug–disease matrix X is discussed.
4.3.2 Building the Input Training Matrix
The input partially observed matrix was constructed based on treatment relations
from UMLS and SemMedDB as indicated in Section 4.2. However, we needed to
consider a larger matrix to fill compared with drugs and diseases of positive indica-
tions from UMLS Metathesaurus and SemMedDB. Otherwise, the test indications in
repoDB cannot be recovered as part of the completion process. For this, we consid-
ered all allowed subject/object semantic type constraints† for treats predicate (based
on SRSTR tables of the UMLS semantic network). Next, we selected all UMLS sub-
ject concepts where each has at least one semantic type that belongs to the set of
allowed subject types; likewise, we aggregated all UMLS concepts where each has at
least one semantic type that is from allowable object types. Based on this, 538,710
subject entities and 314,707 object entities were obtained for the input matrix. How-
ever, most subjects do not have a treatment relation with any disease as observed
†As an example, (Pharmacologic Substance, Disease or Syndrome) is a popular semantic type
combination allowed for treatment relations. (Antibiotic, Disease or Syndrome) and (Therapeutic or
Preventive Procedure, Congenital Abnormality) are less common allowed type combinations. Overall,
there are 56 different allowed type combinations for treatment relations as per UMLS. There are other
additional allowed types that NLM has incorporated as part of the schema design for SemMedDB
and those are included for this effort as allowed combinations.
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in the Metathesaurus training dataset. Hence, we removed all zero rows (hence the
corresponding drugs or treatment agents) and retained only rows that are known to
treat ≥ 1 disease in the columns to exploit the shared therapeutic context among
the drugs. After this pruning process, we were left with 10,188 drugs (or treatment
agents) and 314,707 objects‡ to build our input matrix to be partially filled (from
training datasets) and subsequently completed via NMF. Our initial motivation was
using the hand-curated highly accurate treatment connections from UMLS. Since
the available treatment knowledge in UMLS is limited, we add treatment connections
from SemMedDB to fill the missing cells. This is also a way of imputing knowledge
for some of the missing entries from a different source (even though the accuracy of
this source is not perfect).
To populate the input matrix with training relations, we have Metathesaurus
treatment relations and three different sets of semantic predications derived from
SemMedDB based on extraction frequencies. We have a configuration where training
relations are entered in the tables as 1s, which we call the “binary matrix factor-
ization (BMF)” model. In addition to BMF, we have another configuration using
SemMedDB treatment predications with their extraction frequency counts. We term
this as the “count matrix factorization (CMF)” model to evaluate the perfor-
mance when counts are used instead of Boolean indicators. Finally, as part of the
input we have many unallowed input matrix cells (5,531,386 in total) that cannot be
1s because the corresponding subject–object pairs do not satisfy the domain/range
semantic type constraints. For example, consider this unallowed type combination:
(Drug Delivery Device, Patient or Disabled Group). Although Drug Delivery Device
is an allowed subject type for some other type combination(s) and Patient or Disabled
Group is an allowed object type for a different combination, this particular coupling
is not allowed. However, cells corresponding to this unallowed combination exist in
the input matrix given the matrix was built with all allowed subjects and objects as
rows and columns, respectively. Thus, these cells corresponding to entity pairs that
satisfy this type combination must be designated as unallowed. To avoid such pre-
dictions, we assign 0s to the corresponding cells of the input matrix. This is another
way to further constrain the factorization process to approximate both positive and
unallowed cases while estimating the unobserved cells. The unallowed examples are
‡Note that not all objects are diseases per se, some maybe symptoms and at times different
patient groups. For example, the UMLS CUI C4316221 refers to “Patients with a diagnosis or past
history of total colectomy or colorectal cancer" and can be an object of some treatment relations.
To capture all latent themes we end up using all subjects and objects of treatment relations as part
of the input matrix. However, for evaluation purposes, after NMF, we only look at those cells (in
X̂ from Eq. (4.1)) corresponding to approved and failed indication pairs in repoDB.
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semantically impossible connections that need to ruled out; in this sense, they are
also negative examples. We experimented with several input matrices with different
numbers of unallowed cases to observe their influence on the prediction task. The
levels of these unallowed examples are set to 0% (no unallowed examples), 25%, 50%,
75%, and 100% (all of them) in the input matrix. The overall framework of our
approach is demonstrated in Figure 4.1.
4.3.3 NMF Experimental Configurations
We note that repoDB drugs/diseases for ATs and FIs are already mapped to UMLS
CUIs by its creators. Hence, the matrix constructed and completed as described in
Section 4.3 naturally suffices for the CDR task. When training, experiments were
conducted with singular value decomposition (SVD) to identify a k value (to be used
for the dimensionality in Eq. (4.1)) that minimizes the mean squared error (MSE)
for the cells that are already filled in the training matrix. Since there were not any
noticeable differences between MSE values with k = 50, 100, 500, we chose k = 50 for
our further matrix completion experiments. Thus, results are reported for k = 50 for
all experiments. The regularization parameter β was left at the default value (0.1)
because tuning it did not yield any apparent gains. To carry out the optimization
in Eq. (4.2), the open source MF library LIBMF (Chin et al., 2015) was used for
incomplete matrix approximation with a total of 100 iterations. LIBMF is an effi-
cient stochastic gradient descent based software package that runs parallel on multiple
cores in a shared-memory environment.
Complexity & Running Time Details: For a given n ×m matrix X, the com-
plexity of the matrix factorization is O(kmn) per iteration where k is the latent
dimension (Lin, 2007). This is because computing the value of a single cell requires
k multiplications. The total running time (including finding the best approximation
of the input matrix and the evaluation of the test set by the identified best threshold
value on validation dataset) was nearly one day for each matrix completion configu-
ration.
4.4 Results
We assess NMF results from two different perspectives. First we look the actual NMF
scores produced for ATs, FIs, and RIs we created as part of Section 4.2. Subsequently,
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Table 4.1: Mean of the predicted NMF scores of test sets with different configurations
Model Training Data Test Sets
Portion of included unallowed pairs
0% 25% 50% 75% 100%
BMF UMLS only
Approved treatments 0.958 0.268 0.167 0.102 0.071
Failed indications 0.980 0.119 0.072 0.036 0.020
Random indications 0.995 0.023 0.013 0.009 0.005
BMF
UMLS +
SemMedDB
(MinFreq. 5)
Approved treatments 0.936 0.564 0.559 0.556 0.546
Failed indications 0.957 0.357 0.343 0.331 0.325
Random indications 0.987 0.102 0.100 0.098 0.092
BMF
UMLS +
SemMedDB
(MinFreq. 3)
Approved treatments 0.930 0.614 0.611 0.608 0.597
Failed indications 0.954 0.383 0.371 0.359 0.352
Random indications 0.983 0.139 0.135 0.132 0.124
BMF
UMLS +
SemMedDB
(MinFreq. 2)
Approved treatments 0.927 0.650 0.647 0.645 0.636
Failed indications 0.951 0.413 0.399 0.386 0.381
Random indications 0.976 0.195 0.190 0.186 0.174
CMF UMLS +
SemMedDB
Approved treatments 34.758 7.209 6.194 5.145 3.595
Failed indications 30.327 1.678 3.600 0.981 0.895
Random indications 39.603 1.977 0.689 0.186 0.553
we observe how these NMF scores can be used to come up with the performance
metrics: precision, recall, and F-score based on ATs and FIs from repoDB.
4.4.1 NMF Scores for repoDB Examples
In Table 4.1 we show mean NMF scores for ATs and FIs in repoDB and the RIs we
generated. The scores are real-valued numbers with which NMF fills unobserved cells
as part of the training process for various configurations. Configurations differ from
each other with respect to what is included in the input matrix and the proportions
of unallowed pairs included as 0s. Due to the optimization in Eq. (4.2) and encoding
of positive cases as 1s, the higher the value estimated for an unobserved cell, the
stronger the plausibility of treatment relationship for the corresponding drug–disease
pair. We make the following important observations from Table 4.1
• Only adding positive training examples to the input matrix and leaving unallowed
examples as unobserved (the 0% column) leads to catastrophically bad results
where the FIs and RIs are scoring higher. Hence we do not discuss any results going
forward where the unallowed examples are left as unobserved. Adding additional
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unallowed examples (all other columns) as 0s in the input matrix shows more
realistic scores following a clear pattern where the ATs score higher than FIs,
which fare better than RIs. This confirms a few things: (a). The 0s inserted to
account for unallowed cases are providing enough signal to guide the optimization
process to distinguish between more plausible indications from random ones (which
are mostly useless). (b). NMF based completion is able to score ATs better than
FIs in repoDB where the mean AT score is 2–3 times higher than that of the FI
score, demonstrating its effectiveness. (c). FIs scoring higher than RIs reflects the
reality that FIs actually went through the process of clinical trials, which implies
researchers felt that those pairs were plausible indications; RIs however are just
random pairs of drugs and diseases. (d). Including more unallowed pairs as part of
the input quickly decreases the magnitude of the scores (compare the 25% column
with the 100% column); however, the relative differences between ATs, FIs, and
RIs persist all across the board.
• Adding more training positives from SemMedDB (rows 4–12) increases the absolute
values of the scores and also the differences in scores between ATs, FIs, and RIs,
but the relative differences are the highest when using just UMLS Methasaurus
relations. For example, in the 25% column, the ratio of means of AT and FIs
for “UMLS only” (0.268/0.119 = 2.25) is higher than the corresponding ratio for
“UMLS+SemMedDB (MinFreq. 5)” (0.564/0.357=1.58), which stays at a similar
level even as additional relations are added (MinFreq values 3 and 2).
• Count based models (instead of the binary models) where frequencies are included
in the input matrix appear not as consistent (last three rows) where for the 25%
column, we notice RIs scoring higher than FIs.
We computed 95% confidence intervals that showed that the score differences are
statistically significant. Here we disclose the intervals for the three rows of “UMLS
+ SemMedDB (MinFreq. 2)” (of the 25% unallowed cases column): 0.650 ± 0.010
(ATs), 0.413 ± 0.017 (FIs), and 0.195 ± 0.012 (RIs). In Figure 4.2, we demonstrate
the confidence intervals of the corresponding case graphically. The intervals do not
overlap further confirming the NMF method’s functionality.
4.4.2 Performance Scores for ATs in repoDB
The NMF score ranges in Section 4.4.1 demonstrate that, on average, NMF maps
ATs, FIs, and RIs to non-overlapping segments on the real number scale with high
confidence. However, we still need a way to make repositioning Yes/No decisions
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Figure 4.2: Confidence intervals for UMLS + SemmedDB (Freq.2) with all unallowed
examples
at the instance level based on the score generated for a particular drug–disease pair
corresponding to an entry in X̂ in Eq. (4.1). One way to make such a decision is
to choose a threshold for the NMF score and assign all pairs with scores above that
threshold as new candidates for repositioning. Here we propose to do that by splitting
the repoDB ATs and FIs into validation and test sets. We considered 20% of ATs and
20% of FIs as comprising the validation set while the rest are left for the final test§.
We identified a threshold based on grid search over the validation dataset optimized
for F-score with a small step size of 0.00001 spanning the range [T vmin,Fvmax] such that
T vmin = min({X̂i,j : (i, j) ∈ T v}) and Fvmax = max({X̂i,j : (i, j) ∈ Fv}),
where X̂ is the approximation from Eq. (4.1) and T v and Fv represent the validation
datasets for ATs and FIs, respectively. This range was chosen based on the observation
on the validation dataset that T vmin is smaller than Fvmax (so there were some AT scores
that were less than other FI scores). Hence choosing T vmin as the threshold corresponds
to 100% recall and selecting Fvmax leads to 100% precision. Thus by limiting the grid
search to the threshold range [T vmin,Fvmax], we are exploring the space of compromise
between perfect precision and perfect recall.
Once a threshold is chosen to make instance level decisions for test examples, it is
straightforward to assess the performance of the method using traditional measures
such as precision, recall, and F-score. Thus, in Table 4.2, we report the performance
results for the BMF models for different configurations of the input matrix and differ-
§This translates to 4138 ATs and 1795 FIs in the test set and 1034 ATs and 449 FIs in the
validation dataset — numbers computed based on the original repoDB counts from Section 4.2.3.
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Table 4.2: Performance results of BMF models for approved indications in repoDB
UMLS +
SemMedDB(MinFreq. 5)
UMLS +
SemMedDB(MinFreq. 3)
UMLS +
SemMedDB(MinFreq. 2)
UMLS only
Unallowed cases Threshold P R F-score P R F-score P R F-score Threshold P R F-score
25% 0.00001 0.812 0.942 0.8727 0.808 0.961 0.8787 0.800 0.964 0.8750 0.00003 0.906 0.884 0.8952
50% 0.00001 0.811 0.942 0.8723 0.808 0.961 0.8787 0.800 0.964 0.8750 0.00004 0.906 0.883 0.8950
75% 0.00001 0.812 0.941 0.8721 0.808 0.961 0.8787 0.800 0.964 0.8750 0.00002 0.905 0.878 0.8916
100% 0 0.723 0.981 0.8328 0.714 0.996 0.8322 0.709 0.996 0.8287 0 0.840 0.909 0.8736
ent levels of included unallowed examples. The first observation is that the thresholds
selected are all very close to zero indicating that boundary case NMF scores were close
to zero for ATs across all configurations. The thresholds are identical for configura-
tions with SemMedDB examples but change slightly for UMLS-Only case. We notice
that the best F-score of 0.895 (first row, last column) is obtained for UMLS-Only
input matrix with 25% unallowed example constraints. This may be explained from
the biggest relative difference between mean AT and FI scores for this configuration
from Section 4.4.1. However, adding SemMedDB training instances (with minimum
frequencies 2 and 3) seems to lead to a potentially more desirable compromise with
recall around 96% and precision over 80%. The results for count based CMF models
were disappointing as shown in Table 4.3. There is no clear pattern as to how the
scores are spread with regards to different configurations and overall performance is
all across the board inferior when compared to BMF models especially with substan-
tially lower precision values.
Table 4.3: Performance results for CMF models over repoDB
Unallowed cases Threshold P R F-score
25% 0.12162 0.714 0.957 0.8185
50% 0.08999 0.698 0.968 0.8119
75% 0.00009 0.692 0.973 0.8093
100% 0.005 0.703 0.963 0.8131
4.4.3 Prediction Role of Chronological Treatment Knowledge for Drugs
As we mentioned before, the repurposing of a drug is a convenient way of discovering
new treatment options for diseases. In this context, many drugs have been effectively
applied to treat more than one condition. Hence, we conduct additional experiments
to measure the influence of prior treatment knowledge for the drugs in ATs. When
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we check the AT examples, we notice that there are 394 unique drugs treating more
than one condition (out of 634 pairs).
Since it is hard to trace years of approval for the same drug for different indica-
tions¶, we aggregate the list of publication years of PubMed articles containing the
corresponding TP pairs. Since treatment pairs can appear in multiple publications in
different years, we collect the drug–disease AT pairs in PAT where the corresponding
publications for the disease are chronologically later than PubMed articles for other
diseases the drug treats. As a formal representation,
PAT = {(d, c) : (d, c) ∈ AT, minDate(d, c) > maxDate(d, c′), ∀c′ 6=c (d, c′) ∈ AT}, (4.3)
where AT is the set of ATs and maxDate(d, c) and minDate(d, c) are functions
that indicate the latest and earliest publication dates, respectively, where the corre-
sponding AT pair (d, c) was found to be in a treatment relation as per SemMedDB.
It is clear to see there is at most one pair (d, c) ∈ PAT for any drug d. PAT is our
final test set that contains the latest discovered TP pairs where there can be only
one test pair for each drug as formulated in the Eq. 4.3. Eventually, we obtained 147
pairs in the final test set PAT when we examine the list of drug-disease pairs with
their extraction years. After identifying the temporal test sets, we included the rest
of the AT pairs as the prior knowledge for the temporal test set. Hence, we had 487
additional training treatment pairs.
Table 4.4: Mean of prediction scores of 147 temporal test pairs with and without
temporal data
BMF Models CMF Models
UMLS +
SemMedDB(Freq.5)
UMLS +
SemMedDB(Freq.3)
UMLS +
SemMedDB(Freq.2)
SemMedDB extrac-
tion
frequency count
Included Exceptions w/o Temp. w/ Temp. w/o Temp. w/ Temp. w/o Temp. w/ Temp. w/o Temp. w/ Temp.
25% 0.7559 0.7922 0.8495 0.8568 0.8745 0.8756 1.718 2.602
50% 0.7518 0.7877 0.8458 0.8534 0.8726 0.8724 1.588 2.207
75% 0.7480 0.7840 0.8430 0.8493 0.8703 0.8709 0.872 2.856
100% 0.7378 0.7728 0.8261 0.8366 0.8587 0.8625 0.990 0.796
In Table 4.4, we demonstrate the average prediction scores of the temporal test
set for the BMF and CMF models. In the BMF models, we can clearly see that
using prior knowledge data yields higher scores except for the case using minimum
¶Confirmed by Dr. Oleg Ursu (University of New Mexico), an admin for DrugCentral. He also
informed that a more elaborate effort is needed to glean years for new indications by querying the
Drugs@FDA database to identify Type 6 or Type 9 approvals which designate new indications.
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frequency 2 with 50% of unallowed examples. In addition, increasing the number of
unallowed examples decreases the scores regardless of prior temporal knowledge. In
the CMF scenario, we also have higher scores except for the case using all the unal-
lowed examples when we exploit the prior knowledge of the test pairs. Consequently,
we noticed that the utilization of previously known treatment examples in most of
the models improved the prediction scores of the AT test pairs.
4.5 Discussion
As CDR efforts continue to rise, it is critical to have benchmarking datasets that are
realistic in terms of representation of both approved indications and failed indications.
repoDB is first of its kind dataset that creates such an opportunity to conduct com-
parative evaluations of CDR methods on a publicly available gold standard dataset.
4.5.1 Main Takeaways
Matrix completion through NMF based low-rank approximation is an effective method
for CDR based solely on datasets of previously approved drugs and corresponding in-
dications. Actually, in this manuscript, we only use public data sources of treatment
relations in the form of hand curated UMLS Metathesaurus relations and those ex-
tracted with NLP from PubMed citations (from SemMedDB). As such, these are
imperfect resources (especially SemMedDB) and may not necessarily constitute FDA
approved drugs. Results still show that among recoverable ATs from repoDB, we
achieved F-scores close to 90% with the highest F-score achieved with just UMLS re-
lations as input. Using both SemMedDB and UMLS relations helps achieve a better
compromise between precision and recall with over 96% recall at 80% precision. The
mean NMF score for FIs is at least twice as large as that for RIs, indicating that FIs
are indeed much tougher to distinguish from ATs compared with randomly generated
pairs. A critical enabler was the encoding of unallowed pairs (derived with incom-
patible semantic type constraints from UMLS semantic network) as zeros imposing
additional structural constraints on the input matrix to be approximated. However,
imposing constraints from all unallowed pairs could be detrimental by leading to a
3% recall gain with a 10% precision drop. Experiments showed that introducing 25%
of the zeroes from unallowed pairs leads to better outcomes and is computationally
less expensive. Count based models that consider frequency from SemMedDB sub-
stantially underperform compared with simpler binary models. Overall, NMF based
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methods applied to carefully curated external knowledge sources constitute a practical
approach towards CDR.
Next we discuss some examples of correct predictions made by our approach. In
our training dataset we see the drug vincristine treating malignant neoplasms, follicu-
lar lymphoma, and Hodgkin disease and another drug doxorubicin treating the general
condition of malignant neoplasms. After matrix completion, we saw high values of
0.89 and 0.93 for the entries (doxorubicin, follicular lymphoma) and (doxorubicin,
Hodgkin disease) respectively, which are approved indications in repoDB that were
never encountered in training data and were blank cells before the training process.
Similar new correct predictions are also made for (bleomycin, follicular lymphoma)
and (bleomycin, Hodgkin disease). Next, although, the count based CMF method un-
derperformed overall, there were cases where it lead to correct predications when the
binary approach did not. For example, (betamethasone, berylliosis) and (bleomycin,
malignant head and neck neoplasm) are approved indications that were missed by
the BMF approach but are recovered by the CMF method. Thus there may be some
complementary traits in how the BMF and CMF approaches predict that need further
examination toward building an ensemble method.
We set out to explore reasons for errors — false positives (FPs) and false negatives
(FNs) — incurred by the NMF models in the context of information available about
the corresponding drug–disease pairs. To this end, we examined connectedness of
FP and FN pairs in the SemMedDB graph, which essentially conveys the potential
shared context between associated entities. In our prior work (Bakal et al., 2018),
we identified graph patterns over the SemMedDB graph that are highly indicative of
treatment relations using model coefficients of a logistic regression (LR) model‖. For
FPs of the NMF model, we noticed that there were tens of thousands of highly pre-
dictive short paths (length ≤ 3) connecting the corresponding drug and disease CUIs
indicating that there are many shared neighbors; some of this neighborhood informa-
tion is encoded in the input matrix, which could have led to positive predictions. This
is also not surprising given FPs are essentially failed cases in repoDB but were deemed
plausible enough for researchers to launch clinical trials. For FNs, we found relatively
fewer and sometimes no such predictive paths in SemMedDB connecting associated
entities. For example, for the approved repoDB indication (Dexamethasone, Branch
retinal vein occlusion with macular edema), the drug and disease were not connected
‖The LR model, while being effective, is computational prohibitive at times given the explosion
of numbers of paths connecting entities in a large graph such as that built from SemMedDB. Our
foray into NMF is motivated by these efficiency constraints of the graph pattern based approach.
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in the SemMedDB graph using LR model’s top predictive patterns. Without much
shared context, NMF appears to struggle to elicit positive indications for such pairs.
We plan to pursue a more detailed error analysis involving physician experts, which
may yield additional insights on potential reasons for errors.
4.5.2 Limitations and Future Directions
This current effort is not without a few limitations, which also point to interesting
future research directions for CDR experiments with repoDB.
• The method in this effort is clearly not a silver bullet for CDR. repoDB does enable
excellent benchmarking but in general scientists are often looking at a particular
disease that they want to treat. Hence, for disease specific CDR, more sophisticated
methods involving gene expression datasets and methods that consider integration
of various modalities of information specific to the disease may be needed, as
indicated in other prior efforts (e.g., Nagaraj et al. (Nagaraj et al., 2018) for
cancer). However, our method can be an effective initial step in pruning the
space of candidates before more sophisticated methods that require more complex
modeling and disease specific information can be applied.
• As discussed earlier, the count based CMF models’ performance was underwhelm-
ing (Table 4.3) when compared with the binary models even though the counts
capture additional information about prior knowledge being incorporated into the
input matrix. One reason for this could be that we simply employed raw frequen-
cies of treatment predications in SemMedDB instead of standardizing counts using
well-known methods (Berg et al., 2006) (e.g., mean centering, min-max scaling, log
transformation). Using raw frequencies may have lead to potential ill-conditioning
that needs to be countered with appropriate pre-processing and/or using more so-
phisticated methods (Cichocki and Zdunek, 2006). These experiments will be part
of future extensions of our work.
• Matrix completion methods cannot fill a row that does not have at least one
nonzero entry. In our case, this means, a drug for which we do not have at least
one known treatment relation cannot be linked to new indications with NMF.
However, this can be remedied by moving from matrices to tensors with additional
relations between entities connected with other predicates including prevents, di-
agnoses, affects, and causes. Using tensor factorization (Luo et al., 2016), even
for a drug with no existing treatment relations, using multi-hop indirect connec-
tions, it is possible to elicit a new indication. Similarly, with recent deep learning
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advances, embedding nodes and edges of the larger SemMedDB graph (including
edges arising from other predicates besides treats) with graph neural networks can
offer a different way for knowledge base completion (Schlichtkrull et al., 2018). We
will discuss those approaches in the next chapter.
4.5.3 Benchmarking
To enable future comparisons with our results, we provide the validation/test set splits
of repoDB drug–disease pairs used in this study: https://github.com/bionlproc/
nmf-repoDB-benchmarking. This will be important for direct comparisons by other
researchers using the repoDB dataset, especially given we had to resort to using a
subset of repoDB (owing to issues with lack of training instances for certain drugs
without a single human vetted treatment relation).
4.6 Conclusion
With valuable time and cost savings in the offing, CDR efforts are expected to increase
in the future. With lack of datasets modeling both positive and failed indications, it
is encouraging to notice that datasets such as repoDB are being created. However,
it is also important to start comparing methods against such datasets for robust as-
sessments of different methods. In this chapter, matrix completion through NMF
was used to directly predict repoDB approved indications by using publicly available
treatment relations. F-scores close to 90% were obtained with various training con-
figurations with this method showing its strong potential for practical applications.
Validation and test splits of repoDB used as part of this effort are made available to
facilitate direct comparisons with our results by other researchers in the CDR com-
munity. More sophisticated methods such as tensor factorizations and neural graph
embeddings may hold the promise of recovering novel indications for drug compounds
that have not yet been approved for any known conditions. We believe this is the first
attempt to employ repoDB for CDR purposes and hope that this will trigger more
attempts to pursue this line of work toward rigorous benchmarking.
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Chapter 5 Multi Relational Data Analysis for Drug Repositioning
5.1 Motivation
As we discussed in Chapter 4, the matrix completion approach does not utilize the
indirect connections over multiple biomedical relation types between drug and dis-
ease candidate pairs. To address this weakness, we utilize the available treatment
predications in UMLS and other essential biomedical relation types including pre-
vents, diagnoses, affects, and interacts_with extracted from all of PubMed citations
in SemMedDB knowledge base. For this purpose, in this chapter we conduct experi-
ments exploiting the tensor factorization (TF) algorithm with the 3-way data tensor
input and the graph convolutional neural network (GCN) approach embedding enti-
ties and relations in a vector space.
The TF approach has been successfully applied to diagnostics of test results,
analysis of genomic data, and completion of the electronic health records in the
biomedical domain (Luo et al., 2016; Roy et al., 2014; Wang et al., 2015). Here, the
advantage of the TF method is that the learned low dimensional latent embeddings
capture the underlying patterns among the tensor entries for relation prediction and
other various tasks such as document clustering and recommendation systems. With
this motivation we employed a TF algorithm on the input tensor built with the
biomedical entities connected with multiple biomedical relations. The relations used
in both methods are listed in Appendix A.
Vector embeddings of the nodes and edges in a knowledge graph (a.k.a. - knowl-
edge graph embedding) is extensively studied for the knowledge graph completion
task by several efforts (Nickel et al., 2011; Yang et al., 2014; Wang et al., 2014; Ji
et al., 2015; Trouillon et al., 2016). Similarly, the GCN technique is also utilized for
several tasks such as discovering polypharmacy side effects for drugs, learning molec-
ular fingerprints for drug efficacy, node classification, and predicting relations with
multi-relational data (Zitnik et al., 2018; Duvenaud et al., 2015; Kipf and Welling,
2017; Schlichtkrull et al., 2018). Here, we utilize the embeddings of the semantic
predications from SemMedDB and UMLS repositories. On top of that, we exploit
the GCN algorithm which enhances the entity embedding characteristics by consid-
ering the neighborhood information. The ultimate goal of this chapter is to predict
approved treatments (ATs) and failed indications (FIs) in repoDB with tensor factor-
ization and GCN approaches. Moreover, we demonstrate that these approaches are
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efficient on the relation prediction task with satisfactory performance results.
Overall, we make the following contributions in this chapter:
• We conduct experiments with TF and GCN algorithms to fully exploit the
SemMedDB knowledge base by considering indirect connections over the fun-
damental biomedical relation types as listed in Appendix A.
• We evaluate the models and compare results with the NMFmodel on the repoDB
dataset. Besides, we present the advantages of the TF and GCN models in
recovering new relations missed by the NMF approach.
• We obtain the best performing model with an ensemble of NMF, TF, and GCN
models for the repoDB pairs. In addition, we conduct error analysis with the FP
and FN predictions of the ensemble model by collaborating with two physicians.
5.2 Datasets
In this section, we describe the data sources for our training and testing examples to
evaluate models.
5.2.1 Training Set
SemMedDB and UMLS Metathesaurus are our essential data resources for the train-
ing examples while repoDB is our main resource for the test examples. In order to
obtain the most important predications, we filter them based on the predicates ap-
pearing in the highly indicative semantic patterns∗ of treatment relations in (Bakal
et al., 2018) and the set of predicates of interest in the effort by Cohen et al. (2014).
Essentially, we identified 20 major relations as listed in Appendix A. In our experi-
ments we collected a total of 9,860,059 biomedical predications to use in the training
set.
5.2.2 Test Set – repoDB
As we mentioned in Chapter 4, we totally have 6,218 approved treatments (ATs)
and 2,852 failed indications (FIs) pairs after removing the duplicates and the pairs
which appear in UMLS metathesaurus. Unlike the NMF experiments reported in the
previous chapter, we retained all available test pairs because each entity of the pairs
participates as either subject or object in the training pairs.
∗The predicates were selected from the top 100 patterns that were ranked by the logistic regres-
sion coefficients.
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5.3 Methodologies
As we mentioned in Section 5.1, we conducted experiments using TF and GCN al-
gorithms to predict approved and failed pairs in repoDB. To that end, next we will
briefly explain the technical details of both approaches.
5.3.1 Tensor Factorization Technique
Multi-relational data can be embedded into a multi-dimensional representation such
as a tensor. In this sense, we can generate a three-dimensional input tensor structure
with the biomedical predications to run the TF algorithm. From that angle, we
can simply look at Figure 5.1 to see how we build the mentioned tensor structure
with the biomedical predications. When we look at the tensor figure, we can see
that the structure is a three-dimensional (symbolized as X I×J×K) representation in
which we embed the predications with multiple relations. The y-dimension presents
the subject entities while the x-dimension stands for the object entities, and the
z-dimension indicates different relation types such as treats, causes, and prevents.
Briefly, TF can be considered as a higher-order extension of matrix factorization
that captures the underlying latent patterns in a multi-relational dataset. To this
end, each cell in the tensor presents how many times a relation occurred between
the corresponding entities via the particular relation in SemMedDB knowledge base.
Nevertheless, many of the cells stay blank because those predications do not exist or
are unknown. Therefore, our goal is to discover whether there is a possible relation
for the blank cells.
We exploit the non-negative tensor factorization (NTF) technique. Here,
the non-negativity constraint plays a major role in analyzing non-negative data for
the many practical problems including image processing and text data mining. In
our case, the TF method allows us to detect new context-dependent discoveries of
biomedical relations among entities. The motivation here is that the underlying data
stack is non-negative. Hence, we employ the TF algorithm as the interpretation of
the prediction results is more practical than the usual TF scenario.
To identify the best approximation of a given tensor, there are two well-known
techniques as well as their close variations: Tucker decomposition and CANDE-
COM/PARAFAC (CANonical DECOMposition/PARAlel FACtors – CP) decompo-
sition (Kolda and Bader, 2009). In this research, we utilize the CP decomposition as
it provides a more feasible factorization. Here, the CP tensor decomposition can be
thought of as singular value decomposition (SVD) analog for matrices. SVD decom-
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Figure 5.1: Third order tensor structure representation (X I×J×K) for embedding
biomedical predications.
Figure 5.2: A graphical representation of CP-decomposition mechanism for a three-
way tensor as a sum of rank-one tensors. (Acar et al., 2011)
poses a matrix as a sum of rank-one matrices while the CP technique decomposes a
tensor as a sum of rank-one tensors (Cichocki et al., 2009) as represented schemati-
cally in Figure 5.2.
The example tensor structure X I×J×K is decomposed as three factor matrices
AI×R, BJ×R, and CK×R such that
xi,j,k ≈
R∑
r=1
airbjrckr for i = 1, . . . I, j = 1 . . . , J, k = 1, . . . , K, (5.1)
where R denotes the size of latent dimension while I, J, and K are the numbers
of rows of the factor matrices. For the best approximation, the optimization problem
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in Eq. 5.2 is solved with the CP decomposition.
min
A,B,C
‖X − [[A,B,C]]︸ ︷︷ ︸
Approximated
tensor
X̂
‖2F : A ∈ RI×R+ , B ∈ RJ×R+ and C ∈ RK×R+ (5.2)
In Equation- 5.3, for factor matrices, the parameter R denotes the number of com-
ponents while I, J,K are the numbers of rows in the factor matrices and correspond
to subject entities, object entities, and relations respectively.
f(X ,A,B,C) = 1
2
I∑
i=1
J∑
j=1
K∑
k=1
(
xijk −
R∑
r=1
airbjrckr
)2
(5.3)
Given sparse tensor data, we need to take care of over-fitting issue for better
generalization. As we mentioned in Section 4.3.1, we have a regularization part that
slightly modifies our optimization problem (Acar et al., 2011). Furthermore, in order
to compute the nonnegative component matrices A,B,C, we will apply constrained
optimization approach by minimizing a suitably designed cost function. Typically,
we minimize the following cost function
min
A,B,C
‖X − [[A,B,C]]‖2F +
1
2
(λA‖A‖2F + λB‖B‖2F + λC‖C‖2F )︸ ︷︷ ︸
Regularization part
, (5.4)
where λA, λB, λC are nonnegative regularization parameters. The most popular method
to optimize is to apply the alternating least squares (ALS) technique. In this method
we compute the gradient of the cost function with respect to each individual com-
ponent (factor) matrix (supposing that the others are fixed and independent). In
this sense, among the updating steps, ALS algorithm guarantees minimization of
the cost function, until convergence. The main advantage of ALS algorithms is high
convergence speed and its scalability for large-scale problems.
The main purpose is to identify the best approximation of the input tensor to
analyze the prediction values of the test pairs. All the blank cells will be filled
either with a non-negative real value or zero once we identify the best approximation
similar to the NMF approach. Hence, the prediction task of the missing relations
can be expressed as filling the blank cells in the input tensor such that the predicted
values would be consistent with the existing training examples. Here, we use an
open source TF library, Splatt (Smith et al., 2015) for the approximation of large
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Figure 5.3: A simple graph convolution for a node for graph embedding
incomplete tensors. Technically, the Splatt library takes the advantages of shared
and distributed memory parallelism concepts.
5.3.2 Graph Convolutional Neural Networks Technique
Knowledge base completion or in other words prediction of missing links in knowledge
bases is one of the recently popular challenges in data science (Bordes et al., 2013;
Socher et al., 2013). In this sense, Bordes et al. are the pioneers of the link prediction
task on knowledge graphs (such as Freebase, WordNet, DBpedia and etc.) to predict
new predications (facts) by exploiting deep learning techniques (Goodfellow et al.,
2016). Technically, they embed both entities and relations into the same vector space.
In this context, entities and relations are embedded as vectors such that ei, rj ∈ Rd
(where d is the embedding size). The central idea behind the work is that relations
are called as transitions from an entity to one another so that s + r ≈ o where (s,
r, o) is a triplet (predication). Even though the idea itself is an elegant solution, it
does not involve the neighborhood association data for the entities. Hence, utilizing
the graph convolutional neural networks (GCN) technique on SemMedDB knowledge
graph with the embeddings of the entities and relations is the primary inspiration for
our GCN based experiments.
Technically, convolution operation sums all the neighboring node embeddings for
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both incoming and outgoing edges for every single relation that associates with a
node. Unlike using solely randomly generated embeddings for the entities, we exploit
the convolution operation for a node with its neighbors as depicted in Figure 5.3. In
our case, we embed the entities and relations of the predications in SemMedDB and
UMLS knowledge bases. Each convolution will be occurring in a neural network layer
and the collected information will be passed through the links connecting the nodes
in the graph. Here, in the first layer the entity embeddings are updated via
e
(l+1)
i = σ
(
W
(l)
0 e
(l)
i +
∑
r∈R
∑
j∈N ri
1
cri
W(l)r e
(l)
j
)
(5.5)
where σ(x) represents a non-linear activation function – a rectified linear unit (ReLU),
cri is a normalization constant (showing the number of neighbors via the corresponding
relation r), eli ∈ Rd indicates the latent information of node vi with the dimension d
at the layer l, N ri shows the set of neighbors with relation r ∈ R, while W
(l)
r stands
for the diagonal weight matrix depending on relation r, and W(l)0 indicates a single
self-connection of a special relation type to each node in the graph.
To learn the embeddings for the link prediction task, we used a margin-based loss
function to minimize
L =
∑
(es,r,eo)∈S
(e′s,r,e
′
o)∈S′(es,r,eo)
[d(es + r, eo)− d(e′s + r, e′o) + γ]+, (5.6)
where [x]+ = max(0, x), r ∈ Rd, and γ ∈ {1, 2, 4} is the margin hyper-parameter to
define the margin distance. S is the set of positive pairs while S ′ is the set of negative
pairs. Also, d(·) is the Euclidean distance function that generates lower values for
positive triplets while it generates higher values for negative triplets as explained in
the efforts by Bordes et al. (2012); LeCun et al. (2006).
The embeddings of entities will be initialized running convolution operation while
the embeddings of relations (r ∈ Rd) will be initialized randomly as proposed by Glo-
rot and Bengio (2010). After normalizing the embeddings, a small set of triplets
will be sampled from the training set, and will serve as the training triplets. The
parameters are then updated by taking a gradient step with constant learning rate.
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5.4 Experimental Details
Our knowledge graph is essentially a directed graph with labeled edges from the set
of 20 major relations as listed in Appendix A. Correspondingly, we totally collected
198,738 subject entities, 138,637 object entities, and 20 predicates as depth items
in the partially filled data tensor as input for the TF experiments. Besides, we get
totally 9,860,059 training examples with the combination of SemMedDB and UMLS
predications for both methods. In the TF approach, we have two different scenarios:
binary tensor factorization (BTF) where training relations are represented as 1s
in the input tensor and frequency count factorization (CTF) where predications
have their extraction frequency counts in the tensor cells. In the next subsection, we
will describe the configurations of our models and the details of building the semantic
knowledge graph for the GCN model.
5.4.1 Model Configurations & Details
In the TF experiments, we used an open source incomplete tensor approximation
library, Splatt. The latent dimension k of a tensor to be factorized should be less than
or equal to the minimum of tensor modes’ dimensions. That is we run the experiments
with the latent dimension of 20 which is the number of predicates used in the input
tensor. We chose to leave the regularization parameters λA, λB, and λC as default
(0.01) since tuning them did not yield any obvious gains in the experiments. Toward
convergence based on the optimization equation in Eq. (5.4), a total of 100 iterations
were used for incomplete tensor approximation.
In the GCN experiments, we employed 2-layer (l=2) convolution operation
introduced by Schlichtkrull et al. To minimize the objective function, we selected the
learning rate λ ∈ {0.001, 0.01}, the margin γ ∈ {1, 2, 4} and the latent dimension
k = 50. The optimal configuration was obtained using ADAM (Kingma and Ba,
2014) optimizer with a learning rate (λ) of 0.001, a margin (γ) of 1 , and a minibatch
size of 32. We also applied early-stopping mechanism to avoid over-fitting. In this
sense, training process is stopped early when the F-score performance on the vali-
dation set stops increasing for a particular number of consecutive epochs. We used
early-stopping with 5-consecutive epoch criterion.
Complexity & Running Time Details: For the TF experiment, the complexity
of the tensor factorization is O(kmnl) per iteration where k is the latent dimension,
m is the number of rows, n is the number of columns, and l is the number of relations
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in the third dimension of the tensor. This is basically the total number of multipli-
cations required for each cell in the given tensor (Kolda and Bader, 2009). The total
running time including (identifying the best approximation of the input tensor and
the evaluation of the test set with the found optimal threshold value on the validation
set) was nearly three days for each scenario.
For the GCN experiment, the complexity of the convolution operation over our
knowledge graph is O(nt2) where n is number of nodes and t is the average node
degree in the graph. The total running time of the GCN model (including fitting the
model and evaluating the model with our test set) running on our GPU system was
nearly two days. Overall, comparing all methods used in this dissertation, the most
efficient method is the matrix completion because we have relatively fewer training
examples than other methods and more importantly given it does not have to deal
with other predicates of graph setup used in all other methods. On the other hand,
the most expensive method in terms of the complexity is semantic patterns model
as it needs the extraction of all the possible paths up to a particular length for each
example pair.
5.4.2 Evaluation of Prediction Scores
To assess the predictive power of the models, we need to calculate performance met-
rics (precision, recall, and F-score). This is because we need a threshold ttf above
which we predict an entity pair as positive for the TF models. However, we predict
a test pair as positive if the predicted value is less than the threshold tgcn for the
GCN approach; this is simply because we minimize the distance between the posi-
tive examples. Therefore, we generate a validation set containing randomly picked
instances constituting 20% of positive examples and 20% of negative examples to
explore optimum thresholds for each model.
We identified the threshold ttf based on grid search over the validation dataset
optimized for F-score with a small step size of 0.00001 spanning the range [T vmin, F vmax]
such that
T vmin = min({X̂i,j,z : (i, j) ∈ T v}) and F vmax = max({X̂i,j,z : (i, j) ∈ F v}),
where X̂ is the approximation of the input tensor X from Eq. (5.2), z is the depth
index for the treats relation. Also, T v and F v represent ATs and FIs in the validation
dataset respectively.
For the GCN experiments, we identified the threshold tgcn with the same split of
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validation set and a higher step size of 0.1 spanning the range [F vmin, T vmax]. This is
because we have a higher range of distance scores for the validation set.
5.5 Results & Evaluation
In this section, we first report the performance results of each approach. Then, we
compare the performances with the NMF experiment reported in Chapter 4. In ad-
dition to individual results, we also present the performance scores of the ensemble
of NMF, TF, and GCN models. Furthermore, we show the analysis of utilizing prior
temporal data as we showed in Chapter 4 (Section 4.4.3) for each experiment. Sub-
sequently, we present the experiments of error analysis with the test pairs predicted
as either false positive (FP) or false negative (FN) in our best model.
5.5.1 Performance Evaluation of repoDB Pairs
In Table 5.1, we report the performance metrics of the models in both the TF and
GCN experiments. Apparently, the CTF model has a better performance with the
highest precision than both the BTF model and the GCN model. However, with the
best GCN model, we get 2% lower F-score but achieve 7% higher recall performance
than the best TF model. This is because around 7% recall difference cannot com-
pensate 8% precision drop. On the other hand, binary tensor factorization (BTF)
model yields the lowest scores for each performance measure. This is simply because
the frequency count values provide the CTF model more predictive signal by reflect-
ing the strength of the relations between the corresponding pairs compared to the
BTF model. Ultimately, the tensor factorization approach (with the CTF model)
surpassed the GCN approach with 2% higher F-score.
Table 5.1: Performance results of the repoDB test pairs with TF and GCN methods
Models Precision Recall F-score
CTF model 0.7617 0.9292 0.8371
BTF model 0.6873 0.8184 0.7471
GCN model 0.6880 0.9969 0.8141
5.5.2 Ensemble of Models with Majority Voting
As we mentioned earlier in this section, we compare the best performance results of TF
and GCN methods with our prior NMF based effort presented in the previous chapter.
62
Figure 5.4: The ensemble model structure combining NMF, TF, and GCN models
Since we removed the all zero rows in the input matrix, we were left with 5,172
approved, 2,244 failed pairs in the NMF experiment. Unlike our prior work, there
are 6,218 approved and 2,852 failed pairs available for the TF and GCN experiments
as we mentioned in Section 5.2.2. This is because we utilize 20 relations instead of
applying prediction only based on the treats relation.
Table 5.2: Predictive performance of TF, GCN, and NMF methods for drug resposi-
tioning
Approach Precision Recall F-score
TF 0.7617 0.9292 0.8371
GCN 0.6880 0.9969 0.8141
NMF 0.7882 0.8823 0.8326
To make a fair comparison, we classified the missing test pairs in the NMF effort
by random assignments. In Table 5.2, we present the best performance scores of the
methods. Evidenced by compared performance scores, the TF model outperformed
the NMF and GCN models based on the best F-score achieved. Interestingly, the
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GCN model yielded the best recall and the lowest precision while the NMF model
gained the best precision but has the lowest recall. Beyond that, we also checked the
performances of the missing test pairs on TF and GCN models. We notice that almost
all of the missing approved treatments are predicted as true positive (833 of 836) in
the best GCN model. However, in the TF model, a total of 597 of them are predicted
as true positive. Similarly, the TF model predicts 57 of 487 failed indications as
true negative while the GCN model predicts only 6 of them as true negative. This
indicates that TF and GCN methods are able to catch test pairs by means of indirect
connections of the entities over essential relations (predicates) compared to the NMF
approach. Thus, this outcome motivated us to build an ensemble model with the
majority voting mechanism (Rokach, 2010) as depicted in Figure 5.4.
Table 5.3: The performance scores of the ensemble models for drug repositioning
Missing Pairs Vote Precision Recall F-score
Same as GCN vote 0.7529 0.9957 0.8575
Random distribution 0.7502 0.9748 0.8479
Same as Tensor vote 0.7462 0.9477 0.8350
In the ensemble model experiment, the prediction of the missing pairs in the NMF
model are assigned by three ways: random prediction, same prediction score as in
the best GCN model, and same prediction score as in the best TF model. We re-
port the performance results of ensemble models in Table 5.3. Unlike the individual
performance of each approach, the ensemble approach yields superior prediction per-
formance on the F-score metric. Here, the GCN approach helped the ensemble model
to reach the best recall performance, while the NMF approach maintained the best
precision performance. Thus, we achieved the best F-score performance (85%) with
the ensemble model. Essentially, we realized that the predictions of our models in
the ensemble are complementary for achieving the best trade-off between precision
and recall with the highest F-score.
5.5.3 Performance Evaluation for Prevents & Causes Relations
Although we focus on the drug repositioning pairs in repoDB, we also report the
performance scores of the pairs for the prevents and causes relations in Table 5.4.
We aggregated totally 1,422 and 8,289 pairs as positive from UMLS Metathesaurus
for prevents and causes relations respectively. We also generated same amount of
negative examples as positive pairs as we introduced in Section 3.4.2. Similar to the
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repoDB experiment, we divided the obtained pairs into test (80% of the pairs) and
validation (20% of the pairs) sets. When we compare the performance scores, the
CTF model has a better F-score performance along with the highest precision scores
for both relations. In the best case, we achieved 81% and 75% F-score performances
for prevents and causes relations respectively.
Table 5.4: Performance results for prevents and causes relations with TF and GCN
methods
Prevents Causes
Models Precision Recall F-score Precision Recall F-score
CTF model 0.8727 0.7653 0.8155 0.7734 0.7314 0.7518
BTF model 0.7989 0.7398 0.7682 0.6648 0.7158 0.6894
GCN model 0.5998 0.9972 0.7323 0.6002 0.9996 0.7334
Moreover, the GCN model yielded an exceptional recall score and the worst preci-
sion performance for each relation. Interestingly, the BTF model achieved 3% better
F-score than the GCN model for the prevents relation in consequence of having 20%
higher precision score. On the other hand, the GCN model outperforms the BTF
model with 5% higher F-score performance for the causes relation.
5.5.4 Prediction Role of Chronological Treatment Knowledge
As explained and performed earlier in Chapter 4, we conducted additional experi-
ments to assess the effect of the exploiting prior therapeutic information on training
for the drugs in A instances (ATs). When we check the positive test examples in
repoDB, we notice that there are 516 unique drugs† treating more than one condition.
Next, we aggregate the list of publication years of PubMed articles containing the
corresponding TP pairs. Since treatment pairs can appear in multiple publications in
different years, we collect the drug–disease AT pairs in PAT where the corresponding
publications for the disease are chronologically later than papers for other diseases
the drug treats. Formally,
PAT = {(d, c) : (d, c) ∈ AT, minDate(d, c) > maxDate(d, c′) ∀c′ 6=c (d, c′) ∈ AT}, (5.7)
†Note that we have more unique drugs than the NMF experiments because the missing test
examples are present in this chapter.
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where AT is the set of ATs and maxDate(d, c) and minDate(d, c) are functions that
denote the latest and earliest publication dates discussing the corresponding AT pair
(d, c), respectively. It is straightforward to see there is at most one pair (d, c) ∈ PAT
for any drug d. Ultimately, we obtained 168 pairs in the final test set PAT when we
examine the list of drug-disease pairs with their extraction years. After identifying
the temporal test sets, we included the rest of the AT pairs as the prior knowledge for
the temporal test set. Due to this, we had 513 additional training treatment pairs.
Table 5.5: Average prediction scores of temporal test pairs for drug repositioning with
TF and GCN models
Models w/o Temp. w/ Temp. Improve Rate
CTF model 0.3541 0.6859 48.38%
BTF model 0.0563 0.0565 0.35%
GCN model‡ 7.2992 5.1178 29.88%
In Table 5.5, we demonstrate the average prediction scores of the temporal test
examples for the TF and GCN experiments. Given the results show that the CTF
model achieved the highest improvement (48%) compared to other models. However,
the GCN model also yielded a solid improvement (≈ 30%) while there was almost
no impact of temporal knowledge in the BTF model. Clearly, the reported results
indicate that using prior treatment knowledge of a drug contributes to predicting a
recently discovered therapy for computational drug repositioning efforts.
5.5.5 Error Analysis with FP and FN Predictions on repoDB
To investigate the prediction error of our best model, we conduct error analysis ex-
periments with false positive (FP) and false negative (FN) instances.
5.5.5.1 Medical Evaluation of FP Predictions
As we pointed out in Section 5.2.2, the negative test pairs are selected from clinical
trials database. Thus, the clinical investigations implied a strong treatment possibility
between the entities although the trials failed. To this end, we further examined FIs
which were predicted as positive by each method. This filtration process resulted in a
‡In the GCN experiment, the model is optimized using the euclidean distance function that
generates lower values for positive examples while it generates higher values for the negative examples
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total of 731 FP test pairs§. Next, we ranked the pairs based on their prediction scores
and picked 300 pairs containing the mixture of top 150 and last 150 pairs from the
ranked list. Then, the pairs (sans their ranks) were independently reviewed by two
practicing physicians (Dr. Tushi Singh and Dr. Romil Chadha) at the University of
Kentucky hospital¶. We did not disclose to the reviewers that all pairs were FIs given
we wanted to see which one of those do the physicians think are actually plausible
therapies. The pairs were rated based on the scale in Table 5.6.
Table 5.6: The rating scale for the treatment plausibility rating
Description Rating Score
Strongly disagree 1
Disagree 2
Neutral 3
Agree 4
Strongly agree 5
After they completed independent rating, we found that the ratings of 255 pairs
are either matched or have a difference of one positions. The remaining 45 pairs have
at least two position differences. Next, the raters resolved the conflicts of these 45
pairs to come to a mutually agreed upon rating after face to face discussions.
Table 5.7: Average physician rating scores of biomedical plausibility for drug-disease
pairs
Physician-1 Physician-2
Average Cases Top-150 Last-150 All Top-150 Last-150 All
Before agreement 3.6 3.33 3.48 3.66 3.41 3.53
After agreement 3.65 3.4 3.52 3.62 3.41 3.51
In Table 5.7, we present the average scores of 300 FP pairs rated by medical
domain experts. The difference of average ratings for all pairs dropped to 0.01 from
0.05 after two physicians resolved their disagreements. Given the average rating
scores, it is clear that the physicians ratings align with our model’s predictions, since
the average score is around 3.5 which is higher than the neutral score and lower than
§In the matrix completion experiment, we had 940 FPs while in TF and GCN experiments we
had 1,425 and 2,280 (out of 2,282) FPs.
¶Since finding specific domain experts on each test pair is highly time consuming for the evalu-
ation, we just collaborated with MDs who are working in internal medicine department. However,
evaluation of the test cases with specific domain experts may yield better evaluations.
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the agree score. Furthermore, we found that there is around 6% difference between
the rating scores of the top and last pairs. Thus, we show that our model scores
highlight the relative plausibilities of potential therapeutic connections as rated by
the physicians. More importantly, we note that the manual assigned average rating
of the FP pairs is above ‘neutral’. This is because the examples predicted as FPs are
essentially failed clinical trials in repoDB. Therefore, those were assumed plausible
enough for the medical investigations by researchers.
5.5.5.2 FN Analysis with Semantic Patterns
Unlike the FP pairs, we do not have many test pairs predicted as FNs. Therefore,
we picked three top and three bottom pairs based on their prediction scores from
each method used in the ensemble model (a total of 18 FN pairs). To investigate the
explanations for FNs, we checked the semantic patterns between entities in the pairs
as discussed in Chapter 3. Basically, we examine whether the selected FN pairs are
connected more through the graph patterns that correlate with treatment relations
in comparison with patterns that correlate with the negative class in the treatment
prediction model.
Table 5.8: The average number of matching top semantic patterns for FN pairs
Test Case Negative Patterns Positive Patterns
Top-1K Top-10K Top-1K Top-10K
Top 9 Pairs 430 3483 148 1116
Bottom 9 Pairs 551 4200 178 1291
All 18 Pairs 491 3842 163 1204
We report the number of matching semantic patterns of the FN pairs in top neg-
ative and positive discriminative patterns as shown in Table 5.8. It is clear that the
pairs have more negative patterns connecting them than the positive ones. Thus,
having more indirect associations common in the negative class justifies the FN pre-
dictions of the given test pairs. Since top pairs have fewer matches with the positive
patterns, we can infer that the ranking is reasonable although bottom pairs have more
negative patterns matched.
5.6 Conclusion
Computational drug repositioning is a practical way of expediting the drug develop-
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ment process. In this chapter, we applied tensor factorization and graph convolutional
networks with SemMedDB and UMLS repositories to classify drug repositioning pairs
in repoDB. Moreover, we compared the results with our previous NMF based effort
and built an ensemble method using NMF, TF, and GCN approaches. We achieved
75% precision, 99% recall, and 85% F-score. With the ensemble method, we just
have 3% loss of precision from the best precision case and gained 2% in F-score
compared to the single model giving the best F-score. This is because we did not
have any significant recall drop from the best individual model giving the highest
recall (only 0.12% loss). We conducted error analysis with FP and FN pairs. In
this regard, we justified the FP predictions of our ensemble model by analyzing the
plausibility ratings assigned by medical experts. Similarly, we demonstrated that FN
pair predictions had more semantic patterns matching with top negative patterns
(correlating with the negative class) obtained from the treatment relation prediction
task in (Bakal et al., 2018).
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Chapter 6 Conclusion and Future Work
Discovering new potential treatment options for medical conditions which cause hu-
man disease burden is an essential goal of medical research. However, the excessive
time and financial cost of new drug development are nontrivial obstacles for phar-
maceutics and biomedical communities. Therefore, computational efforts are used to
provide plausible drug candidates for drug repositioning research, which is an efficient
way to complement the traditional drug development strategies. In this dissertation,
we employed supervised machine learning methods that predict approved and failed
drug repositioning pairs with reasonably high predictive performance. In the rest
of this chapter, we present the summary of the contributions to the field and the
limitations of the efforts we demonstrated in the earlier chapters.
6.1 Summary of Contributions
In this dissertation, we presented different machine learning methods for relation
prediction task in drug repositioning research. We list the main contributions in this
research below:
Semantic Patterns over Knowledge Graphs. In Chapter 3, we employed se-
mantic graph patterns extracted from biomedical knowledge graphs connecting pairs
of candidate entities as a set of features to predict treatment and causative relations
between them. To that end, we built various models with logistic regression and de-
cision tree classifiers for the prediction task. We report that semantic patterns over
knowledge graphs hold great promise for global relation prediction in biomedicine.
Moreover, we analyzed the top patterns informed by model coefficients and demon-
strated their interpretability for gaining insights into the prediction process. Also, we
examined false positives with high probability outputs assigned by our model based
on the inputs from practicing physicians.
Non-negative Matrix Factorization. Matrix completion through NMF based low-
rank approximation is an effective method for computational drug repositioning based
on datasets of previously approved drugs and corresponding indications. In Chap-
ter 4, we presented the first effort for repositioning that directly tests against repoDB
instances. By using hand-curated drug–disease indications from the UMLS Metathe-
saurus and automatically extracted relations from the SemMedDB knowledge base,
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we employed non-negative matrix factorization (NMF) methods to recover repoDB
positive indications.
Tensor Factorization & Graph Convolutional Neural Networks. Knowledge
base completion is a popular way of predicting missing links between entities. In
biomedical domain, drug repositioning is a special case of knowledge base completion
by exploring potential new treatment connections between biomedical entities. In
Chapter 5, we built tensor factorization (TF) and graph convolutional neural net-
work (GCN) models exploiting UMLS and SemMedDB knowledge bases to predict
drug repositioning test pairs in repoDB. Furthermore, we compared the performance
scores of the TF and GCN models with the NMF model and generated an ensemble
model using majority voting mechanism with them. We achieved the best prediction
performance with the ensemble model indicating that all three models have comple-
mentary traits.
6.2 Limitations and Future Work
There are some limitations of the models discussed in this manuscript. For the seman-
tic pattern model explained in Chapter 3, our training examples must be connected
in the SemMedDB graph with at least one path. Otherwise, the feature vector will
be a zero vector and will have no information for the prediction task. Another issue
with the LR model is the need to extract the paths connecting entities of length ≤ k.
Even though we handled k = 3 using a straightforward heuristic, we are not aware
of a simple way to do the same for k > 3. A final caveat is that each predicate needs
to have a separate binary model.
For the NMF model in Chapter 4, matrix completion methods cannot populate a
row which does not have at least one nonzero entry (shared contextual information
with other rows). This means, in our case, a drug for which we do not have at
least one known treatment relation cannot be linked to new indications with NMF.
However, we overcame this issue by moving from matrices to tensors with additional
relations between entities connected with other biomedical predicates that are listed
in Appendix A. Consequently, for the TF and GCN models explained in Chapter 5,
we have lower precision scores compared to recall scores (over 90% for both). This
is because the examples predicted as FPs are essentially failed cases in repoDB. That
means that those failed indications were assumed plausible enough for researchers to
launch clinical investigations.
We believe that there are some future directions as follows:
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1. For the count based models in Chapters 4 and 5, we simply employed raw
frequencies of biomedical predications in SemMedDB instead of standardizing
counts using well-known methods (e.g., mean centering, min-max scaling, log
transformation). Thus, using raw frequencies may have lead to potential ill-
conditioning that needs to be countered with appropriate pre-processing and/or
using more sophisticated approaches. We believe that these experiments will
be a part of future work for our NMF and TF efforts.
2. In this dissertation, we have focused on predicting general treatment pairs and
especially drug repositioning pairs in repoDB. However, in general scientists
are often looking at a particular disease that they want to treat. Hence, for
disease specific computational drug repositioning efforts, integration of disease
specific information would be helpful to increase the accuracy of the prediction
for disease specific pairs.
3. In our matrix completion method, we obtained fairly reasonable predictive per-
formance. In light of this outcome, we can exploit this predictive power by
applying the NMF method to slices corresponding to essential predicates (e.g.
stimulates and prevents) from the 3D knowledge tensor that we were factorizing
in the TF method. After obtaining plausible new knowledge with the matrix
completion approach, we can add corresponding new links to update our input
tensor so as to have more existing knowledge (training data) to analyze the
predictive power of the TF approach fed by NMF models.
Copyright c© Mehmet Gokhan Bakal, 2019.
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Appendix A : 20 Major Predicates
• TREATS
• INTERACTS_WITH
• AFFECTS
• COEXISTS_WITH
• ASSOCIATED_WITH
• CAUSES
• INHIBITS
• STIMULATES
• AUGMENTS
• DISRUPTS
• PREDISPOSES
• PREVENTS
• ISA
• ADMINISTERED_TO
• NEG_AFFECTS
• NEG_TREATS
• PRODUCES
• USES
• OCCURS_IN
• SAME_AS
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Appendix B : Abbreviations
ALS Alternating Least Squares. 57
AT Approved Treatment. 53, 54, 65
BTF Binary Tensor Factorization. 60, 62
CDR Computational Drug Repositioning. 7, 35, 36
CNN Convolutional Neural Networks. 11
CP CANDECOM/PARAFAC – CANonical DECOMposition/PARAlel FACtors. 55
CTF Frequency-count Tensor Factorization. 60
CUI Concept Unique Identifiers. 37
DR Drug Repositioning. 35
DT Decision Tree. 4, 20
FDA Food and Drug Administration. 26, 35
FI Failed Indication. 53, 54
FN False Negative. 12, 66
FP False Positive. 12, 31, 66
GCN Graph Convolutional Neural Network. 7, 11, 53, 58, 71
GPU Graphics Processing Unit. 10, 61
LBD Literature Based Discovery. 6
LR Logistic Regression. 4, 17
MeSH Medical Subject Heading. 35
ML Machine Learning. 1
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NLM National Library of Medicine. 14, 35
NLP Natural Language Processing. 1, 6, 36
NMF Non-negative Matrix Factorization. 4, 37, 40, 71
NN Neural Networks. 10
NTF Non-negative Tensor Factorization. 55
SemMedDB Semantic MEDLINE Database. 37
SVD Singular Value Decomposition. 10
SVM Support Vector Machine. 9, 20
TF Tensor Factorization. 53, 71
TP True Positive. 12
UMLS Unified Medical Language System. 37
75
Bibliography
[1] A. B. Abacha and P. Zweigenbaum. “Automatic extraction of semantic relations
between medical entities: a rule based approach”. In: Journal of biomedical
semantics 2.5 (2011), S4.
[2] E. Acar, D. M. Dunlavy, and T. G. Kolda. “A scalable optimization approach
for fitting canonical tensor decompositions”. In: Journal of Chemometrics 25.2
(2011), pp. 67–86.
[3] C. Andronis, A. Sharma, V. Virvilis, S. Deftereos, and A. Persidis. “Litera-
ture mining, ontologies and information visualization for drug repurposing”. In:
Briefings in bioinformatics 12.4 (2011), pp. 357–368.
[4] G. Bakal and R. Kavuluru. “Predicting Treatment Relations with Semantic
Patterns over Biomedical Knowledge Graphs”. In: International Conference on
Mining Intelligence and Knowledge Exploration. Springer. 2015, pp. 586–596.
[5] G. Bakal, P. Talari, E. V. Kakani, and R. Kavuluru. “Exploiting semantic pat-
terns over biomedical knowledge graphs for predicting treatment and causative
relations”. In: Journal of biomedical informatics 82 (2018), pp. 189–199.
[6] R. A. van den Berg, H. C. Hoefsloot, J. A. Westerhuis, A. K. Smilde, and
M. J. van der Werf. “Centering, scaling, and transformations: improving the
biological information content of metabolomics data”. In: BMC genomics 7.1
(2006), p. 142.
[7] A. Bordes, X. Glorot, J. Weston, and Y. Bengio. “A semantic matching energy
function for learning with multi-relational data”. In: Machine Learning (2012),
pp. 1–27.
[8] A. Bordes, N. Usunier, A. Garcia-Duran, J. Weston, and O. Yakhnenko. “Trans-
lating embeddings for modeling multi-relational data”. In: Advances in neural
information processing systems. 2013, pp. 2787–2795.
[9] L. Breiman, J. Friedman, C. J. Stone, and R. A. Olshen. Classification and
regression trees. CRC press, 1984.
[10] A. S. Brown and C. J. Patel. “A standard database for drug repositioning”. In:
Scientific Data 4 (2017), p. 170029.
76
[11] D. Cameron, O. Bodenreider, H. Yalamanchili, T. Danh, S. Vallabhaneni, K.
Thirunarayan, A. P. Sheth, and T. C. Rindflesch. “A graph-based recovery
and decomposition of Swanson’s hypothesis using semantic predications”. In:
Journal of biomedical informatics 46.2 (2013), pp. 238–251.
[12] D. Cameron, R. Kavuluru, T. C. Rindflesch, A. P. Sheth, K. Thirunarayan, and
O. Bodenreider. “Context-Driven Automatic Subgraph Creation for Literature-
Based Discovery”. In: Journal of biomedical informatics 54 (2015), pp. 141–
157.
[13] D. Cameron, R. Kavuluru, T. C. Rindflesch, A. P. Sheth, K. Thirunarayan, and
O. Bodenreider. “Context-driven automatic subgraph creation for literature-
based discovery”. In: Journal of biomedical informatics 54 (2015), pp. 141–157.
[14] L. Cheng, H. Lin, F. Zhou, Z. Yang, and J. Wang. “Enhancing the accuracy of
knowledge discovery: a supervised learning method”. In: BMC bioinformatics
15.12 (2014), S9.
[15] W.-S. Chin, Y. Zhuang, Y.-C. Juan, and C.-J. Lin. “A fast parallel stochastic
gradient method for matrix factorization in shared memory systems”. In: ACM
Transactions on Intelligent Systems and Technology (TIST) 6.1 (2015), p. 2.
[16] A. Cichocki and R. Zdunek. “Multilayer nonnegative matrix factorisation”. In:
Electronics Letters 42.16 (2006), pp. 947–948.
[17] A. Cichocki, R. Zdunek, A. H. Phan, and S.-i. Amari. Nonnegative matrix and
tensor factorizations: applications to exploratory multi-way data analysis and
blind source separation. John Wiley & Sons, 2009.
[18] T. Cohen, D. Widdows, C. Stephan, R. Zinner, J. Kim, T. Rindflesch, and P.
Davies. “Predicting high-throughput screening results with scalable literature-
based discovery methods”. In: CPT: pharmacometrics & systems pharmacology
3.10 (2014), e140.
[19] S. Deerwester, S. T. Dumais, G. W. Furnas, T. K. Landauer, and R. Harshman.
“Indexing by latent semantic analysis”. In: Journal of the American society for
information science 41.6 (1990), pp. 391–407.
[20] J. A. DiMasi, H. G. Grabowski, and R. W. Hansen. “Innovation in the pharma-
ceutical industry: new estimates of R&D costs”. In: Journal of health economics
47 (2016), pp. 20–33.
77
[21] J. T. Dudley, M. Sirota, M. Shenoy, R. K. Pai, S. Roedder, A. P. Chiang,
A. A. Morgan, M. M. Sarwal, P. J. Pasricha, and A. J. Butte. “Computational
repositioning of the anticonvulsant topiramate for inflammatory bowel disease”.
In: Science translational medicine 3.96 (2011), 96ra76–96ra76.
[22] D. K. Duvenaud, D. Maclaurin, J. Iparraguirre, R. Bombarell, T. Hirzel, A.
Aspuru-Guzik, and R. P. Adams. “Convolutional networks on graphs for learn-
ing molecular fingerprints”. In: Advances in neural information processing sys-
tems. 2015, pp. 2224–2232.
[23] R. de Fréin, K. Drakakis, S. Rickard, and A. Cichocki. “Analysis of financial
data using non-negative matrix factorization”. In: International Mathematical
Forum. Vol. 3. 38. Journals of Hikari Ltd. 2008, pp. 1853–1870.
[24] K. Fundel, R. Küffner, and R. Zimmer. “RelEx - Relation extraction using
dependency parse trees”. In: Bioinformatics 23.3 (2007), pp. 365–371.
[25] X. Glorot and Y. Bengio. “Understanding the difficulty of training deep feed-
forward neural networks”. In: Proceedings of the Thirteenth International Con-
ference on Artificial Intelligence and Statistics. 2010, pp. 249–256.
[26] I. Goodfellow, Y. Bengio, and A. Courville. Deep learning. MIT Press, 2016.
[27] A. Gottlieb, G. Y. Stein, E. Ruppin, and R. Sharan. “PREDICT: a method for
inferring novel drug indications with application to personalized medicine”. In:
Molecular systems biology 7.1 (2011), p. 496.
[28] D. Jannach, P. Resnick, A. Tuzhilin, and M. Zanker. “Recommender systems
— beyond matrix completion”. In: Communications of the ACM 59.11 (2016),
pp. 94–102.
[29] G. Ji, S. He, L. Xu, K. Liu, and J. Zhao. “Knowledge graph embedding via
dynamic mapping matrix”. In: Proceedings of the 53rd Annual Meeting of the
Association for Computational Linguistics and the 7th International Joint Con-
ference on Natural Language Processing (Volume 1: Long Papers). Vol. 1. 2015,
pp. 687–696.
[30] R. Kavuluru, C. Thomas, A. P. Sheth, V. Chan, W. Wang, A. Smith, A. Soto,
and A. Walters. “An up-to-date knowledge-based literature search and explo-
ration framework for focused bioscience domains”. In: Proc. of the 2nd ACM
SIGHIT Health Informatics Symposium. ACM. 2012, pp. 275–284.
78
[31] H. Kilicoglu, D. Shin, M. Fiszman, G. Rosemblat, and T. C. Rindflesch. “SemMedDB:
a PubMed-scale repository of biomedical semantic predications”. In: Bioinfor-
matics 28.23 (2012), pp. 3158–3160.
[32] S. Kim, H. Liu, L. Yeganova, and W. J. Wilbur. “Extracting drug–drug inter-
actions from literature using a rich feature-based linear kernel approach”. In:
Journal of biomedical informatics 55 (2015), pp. 23–30.
[33] D. P. Kingma and J. Ba. “Adam: A Method for Stochastic Optimization”. In:
International Conference on Learning Representations (ICLR). 2014.
[34] T. N. Kipf and M. Welling. “Semi-Supervised Classification with Graph Convo-
lutional Networks”. In: International Conference on Learning Representations
(ICLR). 2017.
[35] D. G. Kleinbaum and M. Klein. Logistic Regression: A Self-Learning Text.
Statistics for Biology and Health. Springer New York, 2010.
[36] T. G. Kolda and B. W. Bader. “Tensor decompositions and applications”. In:
SIAM review 51.3 (2009), pp. 455–500.
[37] M. Koudelka and D. J. Dorsey. “A Modular NMF Matching Algorithm for Ra-
diation Spectra”. In: Proceedings of the IEEE Conference on Computer Vision
and Pattern Recognition Workshops. 2016, pp. 18–23.
[38] D. Kuang, J. Choo, and H. Park. “Nonnegative matrix factorization for in-
teractive topic modeling and document clustering”. In: Partitional Clustering
Algorithms. Springer, 2015, pp. 215–243.
[39] Y. LeCun, S. Chopra, R. Hadsell, M. Ranzato, and F. Huang. “A tutorial on
energy-based learning”. In: Predicting structured data 1 (2006).
[40] J. Li and Z. Lu. “A new method for computational drug repositioning using
drug pairwise similarity”. In: Bioinformatics and Biomedicine (BIBM), 2012
IEEE International Conference On. IEEE. 2012, pp. 1–4.
[41] J. Li and Z. Lu. “Pathway-based drug repositioning using causal inference”. In:
BMC bioinformatics 14.16 (2013), S3.
[42] J. Li, S. Zheng, B. Chen, A. J. Butte, S. J. Swamidass, and Z. Lu. “A survey
of current trends in computational drug repositioning”. In: Briefings in bioin-
formatics 17.1 (2016), pp. 2–12.
79
[43] C.-J. Lin. “On the convergence of multiplicative update algorithms for non-
negative matrix factorization”. In: IEEE Transactions on Neural Networks 18.6
(2007), pp. 1589–1596.
[44] Y. Liu, R. Bill, M. Fiszman, T. Rindflesch, T. Pedersen, G. B. Melton, and S. V.
Pakhomov. “Using SemRep to label semantic relations extracted from clinical
text”. In: AMIA annual symposium proceedings. Vol. 2012. American Medical
Informatics Association. 2012, p. 587.
[45] Z. Lu. “PubMed and beyond: a survey of web tools for searching biomedical
literature”. In: Database: the journal of biological databases and curation 2011
(2011).
[46] Y. Luo, F. Wang, and P. Szolovits. “Tensor factorization toward precision
medicine”. In: Briefings in bioinformatics 18.3 (2016), pp. 511–514.
[47] M. Mintz, S. Bills, R. Snow, and D. Jurafsky. “Distant supervision for relation
extraction without labeled data”. In: Proceedings of the Joint Conference of the
47th Annual Meeting of the ACL and the 4th International Joint Conference
on Natural Language Processing of the AFNLP. ACL. 2009, pp. 1003–1011.
[48] K. P. Murphy. Machine learning: a probabilistic perspective. MIT press, 2012.
[49] A. Nagaraj, Q. Wang, P. Joseph, C. Zheng, Y. Chen, O. Kovalenko, S. Singh, A.
Armstrong, K. Resnick, K. Zanotti, et al. “Using a novel computational drug-
repositioning approach (DrugPredict) to rapidly identify potent drug candidates
for cancer treatment”. In: Oncogene 37.3 (2018), p. 403.
[50] National Library of Medicine. Current Hierarchy of UMLS Predicates. http:
//www.nlm.nih.gov/research/umls/META3_current_relations.html.
2003.
[51] National Library of Medicine. Current Hierarchy of UMLS Semantic Types.
http://www.nlm.nih.gov/research/umls/META3_current_semantic_
types.html. 2003.
[52] National Library of Medicine. Semantic MEDLINE Database. http://skr3.
nlm.nih.gov/SemMedDB/. 2016.
[53] National Library of Medicine. SemRep - NLM’s Semantic Predication Extrac-
tion Program. http://semrep.nlm.nih.gov. 2013.
[54] National Library of Medicine. Unified Medical Language System Reference Man-
ual. http://www.ncbi.nlm.nih.gov/books/NBK9676/. 2009.
80
[55] M. Nickel, V. Tresp, and H.-P. Kriegel. “A Three-Way Model for Collective
Learning on Multi-Relational Data.” In: ICML. Vol. 11. 2011, pp. 809–816.
[56] F. Pedregosa, G. Varoquaux, A. Gramfort, V. Michel, B. Thirion, O. Grisel, M.
Blondel, P. Prettenhofer, R. Weiss, V. Dubourg, et al. “Scikit-learn: Machine
learning in Python”. In: Journal of Machine Learning Research 12.Oct (2011),
pp. 2825–2830.
[57] F. Provost and R. Kohavi. “Glossary of terms”. In: Journal of Machine Learning
30.2-3 (1998), pp. 271–274.
[58] S. Riedel, L. Yao, and A. McCallum. “Modeling relations and their mentions
without labeled text”. In:Machine Learning and Knowledge Discovery in Databases.
Springer, 2010, pp. 148–163.
[59] T. C. Rindflesch and M. Fiszman. “The interaction of domain knowledge and
linguistic structure in natural language processing: interpreting hypernymic
propositions in biomedical text”. In: Journal of Biomedical Informatics 36.6
(2003), pp. 462–477.
[60] A. Ritter, L. Zettlemoyer, O. Etzioni, et al. “Modeling missing data in distant
supervision for information extraction”. In: Transactions of the Association for
Computational Linguistics 1 (2013), pp. 367–378.
[61] L. Rokach. “Ensemble-based classifiers”. In: Artificial Intelligence Review 33.1
(2010), pp. 1–39.
[62] S. Roy, R. Homayouni, M. W. Berry, and A. A. Puretskiy. “Nonnegative tensor
factorization of biomedical literature for analysis of genomic data”. In: Data
Mining for Service. Springer, 2014, pp. 97–110.
[63] M. Schlichtkrull, T. N. Kipf, P. Bloem, R. Van Den Berg, I. Titov, and M.
Welling. “Modeling relational data with graph convolutional networks”. In: Eu-
ropean Semantic Web Conference. Springer. 2018, pp. 593–607.
[64] I. Segura-Bedmar, P. Martinez, and C. de Pablo-Sánchez. “Using a shallow
linguistic kernel for drug–drug interaction extraction”. In: Journal of biomedical
informatics 44.5 (2011), pp. 789–804.
[65] S. Smith, N. Ravindran, N. D. Sidiropoulos, and G. Karypis. “SPLATT: Ef-
ficient and parallel sparse tensor-matrix multiplication”. In: Parallel and Dis-
tributed Processing Symposium (IPDPS), 2015 IEEE International. IEEE. 2015,
pp. 61–70.
81
[66] R. Socher, D. Chen, C. D. Manning, and A. Ng. “Reasoning with neural tensor
networks for knowledge base completion”. In: Advances in neural information
processing systems. 2013, pp. 926–934.
[67] R. S. Stafford. “Regulating off-label drug use—rethinking the role of the FDA”.
In: New England Journal of Medicine 358.14 (2008), pp. 1427–1429.
[68] M. Surdeanu, J. Tibshirani, R. Nallapati, and C. D. Manning. “Multi-instance
multi-label learning for relation extraction”. In: Proceedings of the 2012 Con-
ference on Empirical Methods in Natural Language Processing. Association for
Computational Linguistics. 2012, pp. 455–465.
[69] A. Tasneem, L. Aberle, H. Ananth, S. Chakraborty, K. Chiswell, B. J. McCourt,
and R. Pietrobon. “The database for aggregate analysis of ClinicalTrials. gov
(AACT) and subsequent regrouping by clinical specialty”. In: PloS one 7.3
(2012), e33677.
[70] T. Trouillon, J. Welbl, S. Riedel, É. Gaussier, and G. Bouchard. “Complex em-
beddings for simple link prediction”. In: International Conference on Machine
Learning. 2016, pp. 2071–2080.
[71] O. Ursu, J. Holmes, J. Knockel, C. G. Bologa, J. J. Yang, S. L. Mathias, S. J.
Nelson, and T. I. Oprea. “DrugCentral: online drug compendium”. In: Nucleic
acids research 45.D1 (2017), pp. D932–D939.
[72] P. Veličković, G. Cucurull, A. Casanova, A. Romero, P. Liò, and Y. Bengio.
“Graph Attention Networks”. In: International Conference on Learning Repre-
sentations (2018).
[73] B. C. Wallace, K. Small, C. E. Brodley, and T. A. Trikalinos. “Class imbalance,
redux”. In: Data Mining (ICDM), 2011 IEEE 11th International Conference
on. IEEE. 2011, pp. 754–763.
[74] Y.-X. Wang and Y.-J. Zhang. “Nonnegative matrix factorization: A comprehen-
sive review”. In: IEEE Transactions on Knowledge and Data Engineering 25.6
(2013), pp. 1336–1353.
[75] Y. Wang, R. Chen, J. Ghosh, J. C. Denny, A. Kho, Y. Chen, B. A. Malin,
and J. Sun. “Rubik: Knowledge guided tensor factorization and completion for
health data analytics”. In: Proceedings of the 21th ACM SIGKDD International
Conference on Knowledge Discovery and Data Mining. ACM. 2015, pp. 1265–
1274.
82
[76] Z. Wang, J. Zhang, J. Feng, and Z. Chen. “Knowledge graph embedding by
translating on hyperplanes”. In: Twenty-Eighth AAAI conference on artificial
intelligence. 2014.
[77] B. Wilkowski, M. Fiszman, C. M. Miller, D. Hristovski, S. Arabandi, G. Rosem-
blat, and T. C. Rindflesch. “Graph-based methods for discovery browsing with
semantic predications”. In: AMIA annual symposium proceedings. Vol. 2011.
American Medical Informatics Association. 2011, p. 1514.
[78] T. E. Workman, M. Fiszman, M. J. Cairelli, D. Nahl, and T. C. Rindflesch.
“Spark, an application based on Serendipitous Knowledge Discovery”. In: Jour-
nal of biomedical informatics 60 (2016), pp. 23–37.
[79] H. Xu, M. C. Aldrich, Q. Chen, H. Liu, N. B. Peterson, Q. Dai, M. Levy,
A. Shah, X. Han, X. Ruan, et al. “Validating drug repurposing signals using
electronic health records: a case study of metformin associated with reduced
cancer mortality”. In: Journal of the American Medical Informatics Association
(2014), amiajnl–2014.
[80] R. Xu, A. Morgan, A. K. Das, and A. Garber. “Investigation of unsupervised
pattern learning techniques for bootstrap construction of a medical treatment
lexicon”. In: Proceedings of the workshop on current trends in biomedical natural
language processing. Association for Computational Linguistics. 2009, pp. 63–
70.
[81] W. Xu, R. Hoffmann, L. Zhao, and R. Grishman. “Filling Knowledge Base
Gaps for Distant Supervision of Relation Extraction.” In: Proceedings of the
51st Annual Meeting of the Association for Computational Linguistics. ACL.
2013, pp. 665–670.
[82] B. Yang, W.-t. Yih, X. He, J. Gao, and L. Deng. “Embedding entities and
relations for learning and inference in knowledge bases”. In: arXiv preprint
arXiv:1412.6575 (2014).
[83] M. D. Zeiler, D. Krishnan, G. W. Taylor, and R. Fergus. “Deconvolutional
networks”. In: Computer Vision and Pattern Recognition (CVPR), 2010 IEEE
Conference on. IEEE. 2010, pp. 2528–2535.
[84] H. Zhang, M. Fiszman, D. Shin, C. M. Miller, G. Rosemblat, and T. C. Rind-
flesch. “Degree centrality for semantic abstraction summarization of therapeutic
studies”. In: Journal of biomedical informatics 44.5 (2011), pp. 830–838.
83
[85] P. Zhang, F. Wang, and J. Hu. “Towards drug repositioning: a unified compu-
tational framework for integrating multiple aspects of drug similarity and dis-
ease similarity”. In: AMIA Annual Symposium Proceedings. Vol. 2014. American
Medical Informatics Association. 2014, p. 1258.
[86] R. Zhang, M. J. Cairelli, M. Fiszman, H. Kilicoglu, T. C. Rindflesch, S. V.
Pakhomov, and G. B. Melton. “Exploiting Literature-derived Knowledge and
Semantics to Identify Potential Prostate Cancer Drugs”. In: Cancer Informatics
13 (2014), pp. 103–111.
[87] R. Zhang, M. J. Cairelli, M. Fiszman, G. Rosemblat, H. Kilicoglu, T. C. Rind-
flesch, S. V. Pakhomov, and G. B. Melton. “Using semantic predications to
uncover drug–drug interactions in clinical data”. In: Journal of biomedical in-
formatics 49 (2014), pp. 134–147.
[88] Q. Zhu, C. Tao, F. Shen, and C. Chute. “Exploring the pharmacogenomics
knowledge base (pharmgkb) for repositioning breast cancer drugs by leveraging
Web ontology language (owl) and cheminformatics approaches”. In: 19th Pacific
Symposium on Biocomputing, PSB 2014. 2014, pp. 172–182.
[89] M. Zitnik, M. Agrawal, and J. Leskovec. “Modeling polypharmacy side effects
with graph convolutional networks”. In: Bioinformatics 34.13 (2018), pp. i457–
i466.
84
Vita
Name
Mehmet Gokhan Bakal
Education
• 2012–2014 M.S. in Computer Science at University of Kentucky, Lexing-
ton, Kentucky
• 2005–2009 B.S. in Computer Engineering at Trakya University, Edirne,
Turkey
Experience
• 2009-2011 Software Engineer & Certified OpenText Consultant, DDI Technol-
ogy, Istanbul, Turkey
• Summer 2008 Software Engineer Intern, Naryaz Computer and Software Ltd.,
Istanbul, Turkey
• Summer 2008 Software Engineer Intern, BILGEADAM - IT Training & Con-
sulting Company, Istanbul, Turkey
• Summer 2007 Software Engineer Intern, Naryaz Computer and Software Ltd.,
Istanbul, Turkey
Awards
• 2011-2019, A scholarship program for graduate education abroad provided by
Turkish government
Publications
• Gokhan Bakal, Halil Kilicoglu, and Ramakanth Kavuluru. Non-Negative
Matrix Factorization for Drug Repositioning: Experiments with the repoDB
Dataset. To be appeared in the Proceeding of the AMIA 2019 Annual Sympo-
sium.
85
• Bakal G, Talari P, Kakani EV, Kavuluru R. Exploiting semantic patterns over
biomedical knowledge graphs for predicting treatment and causative relations.
Journal of biomedical informatics. 82:189-99; 2018.
• Bakal G, Kavuluru R. On quantifying diffusion of health information on Twit-
ter. In IEEE EMBS International Conference on Biomedical & Health Infor-
matics (BHI); 2017.
• Bakal G, Wallace S, Kavuluru R. On the Predictive Potential of Graph Pat-
terns for Biomedical Relation Extraction. In American Medical Informatics
Association (AMIA) annual symposium; 2016.
• Bakal G, Kavuluru R. Predicting treatment relations with semantic patterns
over biomedical knowledge graphs. In International Conference on Mining In-
telligence and Knowledge Exploration; 2015.
Academic Service
• Reviewed papers for AMIA 2017, 2018, and 2019.
86
